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ABSTRACT 
 
 
The ability of bacteria to detect their surroundings and enact an appropriate 
response is critical for survival. Translation of external signals into a coherent response 
requires specific control over the transcription of DNA into RNA. Much of the 
regulation at this step is accomplished by transcriptional regulators, proteins that bind 
to DNA and alter gene expression. A wide-spread variety of regulators in bacteria is the 
AraC-family. These regulators are divided into two conserved domains and respond to 
a variety of compounds owing to different N-terminal domains. A subfamily of these 
regulators, GATase1-like AraC-family transcriptional regulators (GATRs), is 
described. These proteins contain an N-terminal domain with structural characteristics 
similar to enzymes that synthesize amine-containing compounds. Members of this 
subfamily of transcriptional regulators are found in a wide range of bacteria, however, 
few are characterized. A relatively high number of GATRs are encoded in the 
Burkholderia thailandensis genome. Therefore, we utilized this bacterium as a model to 
explore the function and diversity of these regulators.  
 
 GATRs in B. thailandensis divided into two groups based on 
bioinformatics analysis. The first group includes three members which we identified 
that contribute to the positive regulation of glycine betaine (GB) catabolism. GB can be 
utilized as a nutrient source or as a potent osmoprotectant. The regulation of this 
pathway in B. thailandensis differs from previously established models due to the 
interplay of these regulators. Homologs of two other GATRs in this group were 
identified that regulate carnitine and arginine catabolism. The second group of GATRs 
contains uncharacterized members with no known functions. A genetic strategy for 
engineering constitutive GATRs was developed and employed to investigate the 
transcriptional regulons of these GATRs. This approach yielded the identification of a 
novel GATR that represses expression of an operon producing a formaldehyde 
detoxification system, and is the first example of a GATR that functions as a repressor. 
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CHAPTER 1:  
INTRODUCTION 
1.1 Sensing and responding to the environment. 
 Microbes must be able to survey their molecular surroundings and respond 
accordingly in order to survive and compete in a changing environment. A desiccating or 
nutrient poor environment may prompt a bacterium to undergo a metabolic slowdown to 
conserve resources, or even build a resilient spore (1). Perhaps a bacterium has been 
fortunate enough to colonize a favorable environment and metaphorically stakes its claim 
by building a robust biofilm (2). But how exactly is this achieved? Some signals are 
detected through the membrane by two-component regulatory systems that consist of a 
histidine kinase and a response regulator, which transmit information through 
phosphorylation relays (3). Other molecules may diffuse or be actively transported into 
the cytosol, where they impact the physiology of the cell directly or be detected by one-
component regulatory systems more commonly referred to as transcriptional regulators 
(4). The response to these signals often relies on altering transcription or gene expression 
in the bacterium. 
  Transcription, the conversion of DNA into RNA by protein machinery, is a key to 
the central dogma of biology. DNA provides a master set of plans for the cell and a 
protected library of molecular information. The reading of the DNA and the production 
of RNA transcripts provide a translation of this information into functional directives for 
the cell to follow thus enabling it to persist and multiply. Control over transcription is a 
near universal point of regulation for the activities of all cells. A large portion of this 
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regulation is focused on the activities of the RNA polymerase holoenzyme, which is the 
protein machinery specifically responsible for the mechanistic process of transcription. 
The RNA polymerase must be recruited to the DNA at specific sites to produce 
functionally useful RNA. Transcription regulators bind to DNA elements to specifically 
recruit to or obscure RNA polymerase binding sites. There are a wide range of 
transcriptional regulators, which are classified by the architecture and function of the 
constituent protein domains. 
 
1.2 Glycine betaine as a metabolite and signal. 
  Glycine betaine (GB) is found in abundance in the natural environment. Part of 
the reason for this abundance of availability is the widespread utilization of precursor 
molecules that can be catabolized into GB. Choline, for example, is an important moiety 
for both phosphatidylcholine and sphingomyelin. These phospholipids are major 
components of the plasma membrane, particularly in some eukaryotes (5). Another 
precursor molecule for GB is carnitine. Carnitine is used by eukaryotes in the process of 
transporting lipids across the mitochondrial membrane (6). For these two reasons, GB is 
thought to be particularly abundant in the environmental context of eukaryotes. GB is 
also significant because it is utilized as an osmoprotectant, a compatible solute that 
protects the cell against salt stress, by many prokaryotes, eukaryotes, and archaea (7-11). 
Many organisms can also metabolize GB for growth, using it as either a source of carbon 
or nitrogen (11). The abundance of GB and its metabolites in the environment may 
function as a signal to which bacteria can respond, especially in the context of association 
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with eukaryotes (11). 
  Pseudomonas aeruginosa is both able to utilize GB as an osmoprotectant, and 
contains a catabolic pathway that allows the bacterium to use GB as a nutrient source 
(11). GB and related metabolites in P. aeruginosa also stimulate production of the 
extracellular phospholipase PlcH, a prominent virulence factor (12). GbdR (glycine 
betaine and dimethylglycine response regulator) is responsible for regulating the genes 
that catabolize choline into GB to dimethylglycine, and genes encoding proteins involved 
in the transport of these compounds (13). Two other closely related regulators also 
impinge on the regulation of catabolism related to GB in P. aeruginosa. SouR regulates 
the catabolic genes responsible for converting dimethylglycine to sarcosine and 
subsequently to glycine and serine (14). Additionally, the regulator for the carnitine 
catabolic and transport genes is CdhR (15). Carnitine provides an alternative metabolic 
route to GB. These three regulators share homology and are suggested to bind to the same 
or overlapping sequences in the promoter (14, 16). GbdR, SouR, and CdhR all belong to 
the AraC/XylS family of transcriptional regulators. 
 
1.3 The AraC family of transcriptional regulators.  
  The AraC/XylS-family of transcriptional regulators (ATRs) is one of the most 
common types of prokaryotic transcriptional regulators. The namesake of this family, 
AraC, is responsible for the regulation of the araBAD operon that contains genes for the 
catabolism of arabinose (17-19). ATRs are defined by the homologous ninety-nine amino 
acid residues in the C-terminus of the ATR (20). The C-terminus is characterized by a 
helix-turn-helix DNA-binding domain, followed by a linker region joined to the N-
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terminal region of the protein, typically containing ligand binding and dimerization 
capabilities (21-23) (Figure 1.1). ATRs regulate multiple or single operons, and are often 
themselves encoded divergently from genes they regulate. ATRs target genes that encode 
catabolic enzymes, virulence factors, secondary metabolism, transport, and others (24). 
AraC itself exists as a dimer at normal concentrations, whether or not it is bound to DNA 
and or arabinose (25). AraC regulates the L-arabinose operon by the ‘light switch 
mechanism’ (Figure 1.2). The operon is activated when each monomer binds an 
arabinose molecule, which increases affinity for the two proximal half sites, I1 and I2, 
activating transcription. In the absence of arabinose, one monomer binds I1 while the 
other binds to an alternate half site (O2) which is further upstream, resulting in repression 
of transcription by DNA looping (26). The I1 and I2 half site sequences are composed of 
direct repeat symmetry, as opposed to other transcription factors which have inverted 
repeats (27). This well-studied example has contributed to our general understanding of 
ATRs. However, not all of these insights are broadly applicable to the rest of this family 
of regulators.  
  The other canonical example of ATRs is XylS, which regulates alkyl benzoate 
catabolism and was discovered on the TOL plasmid of Pseudomonas putida (28). Unlike 
AraC, which makes some contacts with the σ70 subunit of RNA polymerase, XylS may 
utilize either σ70 or σ54 at its promoters (28, 29). Another difference is that while it also 
binds to similarly structured half sites and activates as a dimer, XylS typically exists in 
solution as a monomer (30). XylS and other dimerizing ATRs (e.g. RegA) only bind 
target promoters in the presence of the appropriate ligand rather than utilizing the ‘light-
switch mechanism’ (31) (Figure 1.3). Still other ATRs like MarA, SoxS, and Rob, which 
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are involved in E. coli stress response and drug resistance, are examples of ATRs that 
bind promoters in respective regulons as monomers (32).  
  Many of the differences in ATRs stem from differences in the N-terminal domain 
of the protein that imparts ligand specificity and dimerization capacity. Notably, MarA 
and SoxS lack the ligand binding domain characteristic of many other ATRs altogether 
(33). The N-terminal domains of ATRs are derived from the binding domains of other 
protein families. An ATR in Sinorhizobium meliloti contains a cupin-like domain that 
enables a direct interaction with cyclic-di-GMP, quite different from binding sugars as a 
ligand (34). Still others utilize ligands such as urea and bicarbonate (35, 36).  
  The expression of genes coding for ATRs is often tightly regulated in order to 
exert fine-tuned control over the respective regulons. As regulators, the number of 
molecules per cell is often not significantly more than the number of target promoters, as 
is the case for AraC (27, 37). SoxS occurs at approximately 100 molecules per cell while 
impacting the regulation of about one hundred genes (38). XylS concentration per cell 
has also been experimentally determined and is in the range of 200 molecules per cell, 
while its target genes may vary in number due to variable copy number of the TOL 
plasmid (30). Many ATRs, including AraC, participate in some variety of auto-regulatory 
scheme. MarA, an ATR involved in multidrug resistance in pathogenic Escherichia coli, 
has also been demonstrated to bind to its own promoter (39). The turnover rate of MarA 
is only several minutes, allowing the TetR-family repressor MarR, which is located in the 
same operon, to bind in the absence of MarA ligand (33). SoxS and Rob, are ATRs that 
regulate genes in overlapping pathways with MarA and compete for similar promoters 
thus impacting the regulation of MarA induced genes including MarA itself (32).  
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  The transcriptional control of ATR regulons is often also modulated by other 
types of transcriptional regulators, either directly or indirectly. The cyclic-AMP receptor 
protein (CRP), which is involved in the regulation of many genes in E. coli, is required 
for AraC-mediated induction of the L-arabinose catabolic operon (40). CRP is suggested 
to contribute to the relief of the repressive DNA looping caused by AraC as well as assist 
in the recruitment of RNA polymerase through direct contacts (27).  ATRs are subjected 
to anti-activation from a family of proteins designated AraC negative regulators (ANRs) 
(41). These proteins interact with ATRs directly to prevent DNA binding. ANRs also 
interact with HN-S family proteins, which are responsible for DNA condensation and the 
silencing of AT-rich sequences (42). HN-S family proteins may also directly impact 
promoter regions of ATR targets, or the promoters of the ATRs themselves (43). 
 
1.4 Glutamine amidotransferase 1 (GATase 1)-containing AraC family 
transcriptional regulators (GATRs).  
  We identified a subset of ATRs with common homology that we refer to as 
GATRs. GATRs contain two C-terminal helix-turn-helix motifs like other ATRs, but the 
N-terminal domain bears homology to Class I GATases (Figure 1.4), a family of enzymes 
that catalyzes the transfer of amide groups to various substrates. The distribution of these 
regulators is quite broad, including both Gram-positive and Gram-negative bacteria 
(Figure 1.5), however there are few characterized representatives of this type of ATR. 
These GATRs are particularly common amongst the Proteobacteria. The genomes of 
many members of the Proteobacteria contain multiple GATRs, rather than just one or 
two. Interestingly, GATRs are also found in eukaryotes including the pharaoh ant, pea 
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aphid, and Entamoeba histolytica (44). Many GATRs are labeled as FtrA or FtrA-like, 
owing to a described GATR in Caulobacter crescentus, which is suggested to be a 
putative regulator under limited oxygen conditions of an alternative branch of the 
thiamine synthesis pathway, myo-inositol degradation, and two aminotransferases (45). 
Analysis of amino acid sequence homology and synteny of adjacent genes reveals 
GATRs designated FtrA are unlikely to be orthologous and likely to have differential 
functions. Some GATRs contain a conserved cysteine residue within the N-terminal 
domain, which is a characteristic of the GAT superfamily of which GATases are part. 
  Members of the GAT superfamily of proteins are typified by a variable strand 
number Rossmann fold (46), which is series of parallel β-sheets suggested to play a role 
in nucleotide binding (47). This superfamily includes a wide variety of proteins with well 
characterized functions aside from the GATases. These include proteases like Pfp1 from 
the Archean Pyrococcus furiosus (48), and the chaperone Hsp31 in E. coli (49). The yeast 
homolog of Hsp31 in addition to chaperone activity, has a methylglyoxal detoxification 
activity under conditions of oxidative stress (50). Many members of the GAT 
superfamily appear to be evolutionary derivatives of ThiJ, a bacterial protein involved in 
the synthesis of thiamine (51). This includes the human protein DJ-1, which is protective 
against oxidative stress in the brain and associated with Parkinson’s disease (52, 53). The 
GAT superfamily also shares evolutionary features with catalases, and typical sub-
families may differ by the size of a variable region between strands of the Rossmann fold 
and occasional lack of the typical catalytic triad, cysteine-histidine-aspartate/glutamate 
(46). The superfamily is rounded out by particular members of the AraC-family (GATRs) 
and the GATases.  
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  GATases are known to be involved in the biosynthesis of a wide variety of 
aminated molecules including amino acids, aminated sugars, nucleotides, and more (54). 
GATases typically utilize glutamine as the nitrogen donor, but some utilize primarily 
exogenous ammonia instead of or in addition to glutamine. The only noted exception is 
Glu-tRNAGln amidotransferase, which also utilizes asparagine at a low rate (55). 
GATases are divided both functionally and topologically into two domains of a monomer 
or as heterodimers of translationally separate subunits (56, 57).  
  The first domain, referred to as the GAT (glutamine amidotransferase) domain, 
consists of both the amine binding and amindotransferase activity. The second domain 
contains the synthase activity and is generally quite divergent owing to the chemically 
diverse amide receptors participating in the reaction to generate a particular product. The 
liberated ammonia is shuttled through a molecular channel between the amidotransferase 
and synthase domains (58-60).  
  The GAT domain is divided into two distinct classes, as defined by sequence 
homology (61). Class 1 has a conserved catalytic triad consisting of a cysteine, histidine, 
and glutamine. Class 2 members possess a single highly conserved cysteine in the amino 
terminus. The remaining amino acid residues of the catalytic triad are less well 
conserved.  
  The first characterized GATR was ArgR in P. aeruginosa. ArgR regulates the 
arginine succinyltransferase pathway of arginine catabolism (62). Although P. 
aeruginosa has three additional pathways for arginine utilization, it is unable to use 
arginine as a sole carbon source in the absence of argR (63). In P. aeruginosa, ArgR also 
plays a critical role in the catabolism of lysine. This is due to the requirement of ArgR for 
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expression of the ldcA gene which codes for a decarboxylase critical for the catabolism of 
lysine and its use as a sole carbon source (64). ArgR is unrelated to the similarly named, 
hexameric regulation protein found in E. coli and other enterics despite regulating similar 
components of the metabolic pathway (65, 66). The remaining recently characterized 
GATRs are implicated in different branches of GB catabolism in P. aeruginosa. 
 
1.5 Burkholderia thailandensis as a model organism. 
  GATRs are especially prevalent in Burkholderia. B. thailandensis in particular 
possesses thirteen bioinformatically predicted GATRs (Figure 1.7). Because many 
examples of GATR-containing microorganisms only have one or two putative GATRs, a 
sample size of thirteen represents a significant survey of GATRs with respect to their 
different functions. For this reason, and the fact that B. thailandensis is a genetically 
tractable model organism for which there are preexisting genetic tools (67-69), we have 
concentrated our efforts on exploring this subset of GATRs in order to achieve a greater 
understanding of GATRs as a family. 
  Burkholderia thailandensis is a saprophytic, β-proteobacteria associated with the 
rhizosphere. The genome is arranged as two circular chromosomes possessing 5712 
genes over 6.7 megabases (strain E264) (70). This genome is larger compared to familiar 
bacteria such as E. coli K-12 at 4.6 megabases, which indicates an increased number of 
genes based on the relatively linear correlation between genome size and the number of 
genes in bacterial species (71). A larger number of genes suggest an enhanced ability to 
take advantage of a larger diversity of compounds found in the environment, and is 
typical of free-living bacteria isolated from the environment (72). Initially, Burkholderia 
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species fell under the genus Pseudomonas due in part to metabolizing a similar array of 
compounds and filling a similar environmental niche. Burkholderia are now recognized 
as an independent genus (73), and have undergone several reclassifications in the 
scientific literature (Figure 1.6). More recently, a large number of primarily 
environmental Burkholderia have been reclassified and placed in the new genus, 
Paraburkholderia (74).  
  Burkholderia thailandensis was originally isolated from rice paddy soil samples 
in Thailand and recognized as distinct from the pathogenic Burkholderia pseudomallei 
due to its ability to catabolize arabinose and an apparent lack of clinical cases caused by 
any isolates with this ability (75-77). It is considered avirulent, and classified as a 
biosafety level 1 organism by many research institutions. Burkholderia species also tend 
to be naturally resistant to many antibiotics due to their contingent and variety of 
antimicrobial pumps and capsules (78). The metabolic flexibility of many 
Burkholderiales has made them a focus for studies in bioremediation (79). Burkholderia 
species are also notable for their capacity to produce secondary metabolites, including 
antifungal compounds (80, 81).  
  Utilizing B. thailandensis as a model organism has the advantage of serving as a 
substitute for its more pathogenic relatives due to its close genetic similarity (70). The 
Burkholderia genus can be roughly subdivided into two further distinct clades. The first 
group includes Burkholderia pseudomallei and Burkholderia mallei, potent pathogens 
and select agents. It is to this group that B. thailandensis is most closely related and the 
three organisms are thought to share a core metabolic genome (70). In addition, B. 
thailandensis also possesses many genes associated with virulence including fimbriae, 
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several capsule operons, several type III secretion systems, several type-VI secretion 
systems, and flagella suited to both extracellular and intracellular lifestyles (82). The 
presence of these virulence-associated genes in B. thailandensis may be related to the 
antagonistic and symbiotic interactions of these and other Burkholderiales have with 
different amoeba species (83-85). Members of this clade are also able to stimulate the 
fusion of different phagocytic cells into multinucleated giant cells in both humans and 
arthropods (86-88). The second group includes Burkholderiales that are often members of 
the rhizosphere or plant pathogens. This second group is also notable for including the 
namesake organism of the genus, Burkholderia cepacia, a pathogen of the onion plant 
that infiltrates the onion causing a tannish to yellow ooze of bacteria and rendering it 
inedible (89) (Figure 1.8A). However, these organisms may cause opportunistic 
infections in humans, particularly in immune compromised individuals. The best example 
of this opportunistic pathogenicity is in patients with cystic fibrosis (CF) where many of 
these Burkholderiales make up what is known as the Burkholderia cepacia complex 
(Bcc) and greatly increase morbidity (90). Similarly to the Pseudomallei group, B. 
thailandensis shares a large portion of its genes with members of the Bcc, but has the 
advantage of genetic tractability as the genomes of Bcc members are notoriously 
genetically malleable due to recombination between insertion elements, and are 
consequently less facile for genetic experimentation (91).  
  As a model for B. pseudomallei is particularly advantageous because B. 
thailandensis is significantly less virulent in mammals, and therefore less hazardous for 
laboratory work (92, 93). Although B. thailandensis retains the ability to live 
intracellularly in eukaryotic cell culture, the lack of a major capsule representing a 
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primary virulence factor in B. pseudomallei, allows the bacterium to be rapidly cleared by 
the innate immune system (94). Ultimately, the only incidents of disease attributed to B. 
thailandensis are a car accident were an infant was ejected from the vehicle into a 
drainage ditch (95), a traumatic leg amputation due to a motorcycle incident (96), and an 
unusual case of fever in an elderly man in Chongqing, China (97). In all of these cases, 
infection caused by B. thailandensis does not seem to be the primary health concern and 
the ability to identify the causative agent in a clinical setting can be limited by available 
resources and ability to isolate the correct bacterium.  
  B. pseudomallei is the causative agent of melioidosis, a disease that is rapidly 
gaining recognition in developing countries. Melioidosis, also known as Whitmore’s 
disease after it’s discoverer Alfred Whitmore (98) (Figure 1.8B), is difficult to diagnose 
in part because it has similar symptoms to other common illnesses and many countries 
where it is endemic lack the clinical facilities needed to accurately identify it (99). The 
infection has often progressed to an advanced stage by the time it is identified, often 
when abscesses are detectable on the spleen and other internal organs when the patient 
already may be septic. In addition, B. pseudomallei infection may be latent for an 
indeterminate amount of time before becoming active. The exact means by which this 
occurs is unknown, but may have to do with the ability of B. pseudomallei to infiltrate 
immune cells and survive intracellularly. Due to this ability, the illness was previously 
known as the “Vietnam Time Bomb”, as American veterans of the Vietnam War might 
not become ill until years after returning home with one documented case occurring after 
sixty years. This phenomenon was particularly prevalent among helicopter crews, 
perhaps due to the generation of dust particles upon takeoff and landing (100). There are 
13 
 
a predicted 165000 cases of melioidosis per year with an approximately fifty percent 
mortality rate based on computer models (101). Infection may manifest a number of 
symptoms and result in abscesses and septic shock (102). Cases of melioidosis 
correspond to seasonal monsoons, possibly due to the resulting rising water table or the 
disturbance of the soil (103, 104). B. thailandensis and B. pseudomallei may directly 
compete for the same environmental niche, as isolation of these organisms in 
Northeastern compared to other regions of Thailand favors B. thailandensis and 
correspond with a lower level of melioidosis cases (105) (Figure 1.9). Additionally, B. 
pseudomallei and B. thailandensis both can compete experimentally with their multiple 
contact dependent inhibition systems, type-IV secretion systems, in addition to other 
systems (106-108). 
  The select agent status of B. pseudomallei and B. mallei also contribute to the 
difficulty of working with these pathogens. B. mallei is an extremely close relative of B. 
pseudomallei that has been genetically reduced putatively due to the high presence of 
transposons in its genome. As a consequence, B. mallei is an obligate intracellular 
pathogen and has never been isolated from soil. It is the causative agent of glanders in 
equines (horses, donkeys, mules) (Figure 1.8C), although it can also infect humans who 
have been in contact with infected equines (109). Due to efforts to eradicate infected 
animals, the last natural case of glanders in the United States occurred in 1937. However, 
it is still endemic in other countries where the use of equines as beasts of burden is 
common (109).  B. mallei was actively used as an agent of biological warfare during 
World War I by Germany in an effort to sabotage the supply of horses to Europe from the 
United States (110). B. pseudomallei was also researched biological weapon by the 
14 
 
infamous Japanese unit 731 during World War II were the notable ability of B. 
pseudomallei to persist in pure water for long periods of time was exploited to 
contaminate well water in China (111). The potential of B. pseudomallei for use as a 
biological weapon was also researched by the Soviet Union as part of their notorious 
Biopreparat biological weapons program (112). Due to this colorful history, the politics 
and legal restrictions on studying these pathogens impose great monetary costs and 
hurdles to research. This makes the avirulent B. thailandensis an attractive, cost-effective 
alternative model organism.  
 
1.6 Focus of study and approach. 
 The work in this thesis focuses on understanding the role of GATRs in the context 
of B. thailandensis. Because of the importance of GB catabolism, we first sought to 
identify an ortholog for GbdR (113). In Chapter 2 we identify multiple orthologs of 
GbdR and describe an alternative model for regulation of the GB catabolic pathway. 
Regulons for the identified GATRs are determined through RNA-Seq, reporter assays, 
and electro mobility shift assays. Chapter 3 describes our efforts to identify the function 
of additional GATRs in B. thailandensis. Strains with constitutive GATRs were 
generated by combining structural data with information about known constitutive 
mutations in a characterized GATR. This allowed for the determination of the regulon of 
an unknown GATR, I0685. I0685 is the first GATR found to act as a repressor, and 
prevents expression of a formaldehyde detoxification system. Two other GATRs were 
characterized by screening B. thailandensis GATR deletion strains against a small library 
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of compounds used in growth assays as either a sole carbon or sole nitrogen source. 
Finally, Chapter 4 explores the significance of these findings, what unanswered questions 
remain, and suggests future experiments to expand on these studies.  
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1.7 Chapter 1 Figures 
 
Figure 1.1 – General Representation of ATRs. 
AraC-family transcriptional regulators are separated into an N-terminal and C-terminal 
domain, joined by a short linker. The N-terminal domain includes both effector binding 
and dimerization capacity. A short N-terminal arm, which affects the nature of the 
dimerization interaction, is also present. The C-terminal domain imparts DNA binding 
ability and consists of two helix-turn-helix (HTH) motifs.  
 
Figure 1.2 – The light-switch mechanism of AraC. 
Figure adapted from Yang et al. (31). (A) The schematic of AraC and the ‘light-switch 
mechanism’ are a model for the understanding of ATRs. (B)  The AraC dimer binds to 
the upstream element O2 and I1 of the araBAD promoter in the absence of arabinose 
ligand. (C) In the presence of ligand, the N-terminal arm changes arrangement, affecting 
the dimerization interaction and preference for half sites to the I1 and I2 sites, making the 
complex capable of activating transcription.  
 
Figure 1.3 – Mechanism of RegA. 
Figure adapted from Yang et al. (31). (A) In the absence of ligand, RegA remains 
unbound. (B) In the presence of its ligand, HCO3- (bicarbonate), RegA binds to and 
activates its target promoters.  
 
Figure 1.4 – General Representation of GATRs. 
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GATRs are markedly similar to other ATRs, consisting of similar functional domains. 
However, the N-terminal domain is homologous to glutamine amidotransferase class 1 
enzymes (GATase1).  
 
Figure 1.5 – Distribution of GATRs. 
(A) Protein architecture used for Conserved Domain Architecture Retrieval Tool 
(CDART) query to find GATRs in the NCBI non-redundant protein sequence database 
(44). (B) Result of query showing the broad presence of GATRs in bacteria, particularly 
proteobacteria, and several examples in eukaryotes.  
 
Figure 1.6 – Phylogeny of Burkholderia.  
The Burkholderia genus may be broken up into a group containing pathogens similar to 
B. pseudomallei, a group encompassing opportunistic pathogens that include members of 
the BCC, and phytopathogens. Many classical members of the genus can now be 
separated into the new, but closely related genus, Paraburkholderia. This phylogenetic 
tree was generated using PATRIC (114).  
 
Figure 1.7 – GATRs in B. thailandensis. 
GATRs, and rough schematics of their genomic context bioinformatically, predicted in B. 
thailandensis by BLAST homology to GbdR from P. aeruginosa. GATRs are depicted in 
magenta, while other predicted genes are depicted in yellow. 
  
Figure 1.8 – Beware of Burkholderia.  
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Members of the Burkholderia genus may cause a variety of diseases in plants and 
animals. (A) Example of sour skin of onion caused by B. cepacia (115). (B) Medical 
examples of cutaneous melioidosis in patients (116). (C) A horse afflicted with Glanders, 
caused by B. mallei. Source: The Brooke Hospitals for Animals 
(https://www.thebrooke.org/our-work/india/glanders-impact-horse-owners)  
 
Figure 1.9 – Global endemicity of melioidosis.  
Figure adapted from Center for Disease Control website. Cases of melioidosis are 
generally concentrated near the tropical regions, particularly in South East Asia. 
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2.1.1 Abstract 
  Burkholderia thailandensis is a soil-dwelling bacterium that shares many 
metabolic pathways with the ecologically similar, but evolutionarily distant, 
Pseudomonas aeruginosa. Among the diverse nutrients it can utilize is choline, 
metabolizable to the osmoprotectant glycine betaine and subseqeuntly catabolized as a 
source of carbon and nitrogen, similar to P. aeruginosa. Orthologs of genes in the choline 
catabolic pathway in these two bacteria showed distinct differences in gene arrangement 
as well as an additional orthologous transcriptional regulator in B. thailandensis. In this 
study, we showed that multiple glutamine amidotransferase1 (GATase1)-containing 
AraC-family transcription regulators (GATRs) are involved in regulation of the B. 
thailandensis choline catabolic pathway (gbdR1, gbdR2, souR).  Using genetic analyses 
and sequencing the transcriptome in the presence and absence of choline, we identified 
the likely regulons of gbdR1 (BTH_II1869) and gbdR2 (BTH_II0968). We also identified 
a functional ortholog for P. aeruginosa souR, a GATR that regulates the metabolism of 
sarcosine to glycine. GbdR1 is absolutely required for expression of the choline catabolic 
locus, similar to P. aeruginosa GbdR, while GbdR2 is important to increase expression of 
the catabolic locus. Additionally, the B. thailandensis SouR ortholog (BTH_II0994) is 
required for catabolism of choline and its metabolites as carbon sources, whereas in P. 
aeruginosa, SouR function can by bypassed by GbdR. The strategy employed by B. 
thailandensis represents a distinct regulatory solution to control choline catabolism and 
thus provides both an evolutionary counterpoint and an experimental system to compare 
the acquisition and regulation of this pathway during environmental growth and infection.  
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2.1.2 Importance 
  Many proteobacteria that occupy similar environmental niches have horizontally 
acquired orthologous genes for metabolism of compounds useful in their shared 
environment. The arrangement and differential regulation of these components can help 
us understand both the evolution of these systems and the potential roles these pathways 
have in the biology of each bacterium. Here we describe the transcriptome response of 
Burkholderia thailandensis to the eukaryote-enriched molecule choline, identify the 
regulatory pathway governing choline catabolism, and compare the pathway to that 
previously described for Pseudomonas aeruginosa. These data support a multi-tiered 
regulatory network in B. thailandensis, with conserved orthologs in the select agents 
Burkholderia pseudomallei and Burkholderia mallei, as well as the opportunistic lung 
pathogens in the Burkholderia cepacia clade.  
 
2.2 Introduction 
  Burkholderia thailandensis is a saprophytic, soil dwelling bacterium common in 
tropical and subtropical regions, and is an opportunistic pathogen of insects, plants, 
nematodes, and amoeba (1-3). B. thailandensis is used as a less virulent model for the 
select agents B. pseudomallei and B. mallei, the causative agents of melioidosis and 
glanders, respectively. The reduced virulence of B. thailandensis is primarily due to the 
absence of the major capsule locus important for B. pseudomallei virulence in mammals 
(4), although it is used to study the effect of type III section systems on phagocytic 
escape and retains other genes associated with virulence (5, 6). Despite virulence 
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differences, a great deal of the core genome is shared between B. thailandensis and its 
relatives, including many pathways for accessory metabolism.  
  Genes predicted to be involved in choline catabolism are found throughout the B. 
pseudomallei group (BPG) and Burkholderia cepacia complex (BCC) (7, 8). Many soil 
bacteria can use choline as a sole carbon and nitrogen source, and this catabolic pathway 
may be particularly important for bacteria associated with eukaryotes (9). Choline is part 
of the polar head group of both phosphatidylcholine and sphingomyelin, which together 
constitute the majority of lipids on the outer leaflet of eukaryotic cell membranes (10), 
and are also abundant in pulmonary surfactant (11). In addition to its role as a nutrient 
source, choline metabolism can generate glycine betaine (GB), an important 
osmoprotectant  (12) and inducer of virulence factor production (13). The conversion of 
choline to GB has been shown to be important for Escherichia coli survival in urine (14) 
and P. aeruginosa survival in the mammalian lung (15, 16). Many organisms, including 
Burkholderiales, maintain an intracellular GB pool, potentially as a hedge against future 
osmotic stress (17).  Choline can also be found in the rhizosphere, exuded from plant 
roots, likely to influence populations of bacteria in this environment (18). In fact, many 
plants accumulate high levels of GB as an osmoprotectant, notably beets from whence the 
appellation ‘betaine’ was derived (19). In the environment, secreted or decaying organic 
matter provides a metabolic opportunity that holds much promise to microbial 
opportunists poised to exploit them.  
Our lab has previously studied the choline catabolic pathway and its regulation in 
Pseudomonas aeruginosa (20-22), and examination of orthologous genes in B. 
thailandensis suggested an alternate, perhaps more complex, regulatory strategy. In P. 
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aeruginosa, the critical regulator of GB catabolism is GbdR, a type-I glutamine 
amidotransferase (GATase1)-like AraC-family transcription regulator (GATR) that 
regulates the genes required for sequential demethylation of GB to glycine in P. 
aeruginosa (Fig 2.1A, left side)  (22). In contrast to P. aeruginosa, B. thailandensis and 
other Burkholderiales appeared to have two GbdR orthologs (Fig 2.1B, C), whose co-
occurrence and conserved synteny suggested that they could play non-overlapping roles 
in B. thailandensis choline catabolism. In this study, we have investigated the 
contributions of the two B. thailandensis GbdR orthologs to choline and GB catabolism 
and to global gene expression in response to choline. These data and follow-up analyses 
reveal that the choline catabolism pathway in B. thailandensis, while bearing many 
similarities to P. aeruginosa, contains key differences in organization and regulation.    
 
2.3 Methods 
2.3.1 Culture conditions.  
Burkholderia thailandensis E264 (ATCC® 700388™) (23) cultures were 
inoculated from -80 oC glycerol stocks onto LB (10 g/L tryptone, 5 g/L yeast extract, 5 
g/L NaCl) with 1.5% agar and incubated at 37 oC overnight. For protein expression and 
molecular cloning, Escherichia coli DH5α or E. coli T7 express cells (New England 
BioLabs (NEB)) were then grown in LB broth containing 100 µg/mL carbenicillin, 
kanamycin, or trimethoprim (Tp), as appropriate.   
 
2.3.2 Strain Construction.  
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Deletion strains (Table S1) were generated as described in Thongdee et al. and the 
resistance markers were removed using the methods described in Choi et al. (24, 25). 
Briefly, a PCR product was amplified via splice overlap extension PCR that consisted of 
a trimethoprim resistance marker amplified from pUC18mini-TN7T-Tp, including the 
flanking Flp recombinase sites, and with regions of homology upstream and downstream 
of the gene of interest (See primers in Table S2). The resultant PCR product was then 
used to naturally transform B. thailandensis that had been grown in defined media (DM) 
as previously described [24].  To remove the resistance marker, pFLPe2 was 
electroporated into the Tp resistant strain and plated onto low-salt LB (LSLB: 10 g/L 
tryptone, 5 g/L yeast extract, 3 g/L NaCl, 1.5% agarose, pH 7.5 with 250 µg/mL zeocin 
and 0.2% L-rhamnose for Flp recombinase expression). Cells were cured of pFLPe2 by 
growth at 42 oC. Resultant colonies were streaked onto plates with zeocin, Tp, or without 
antibiotics to identify colonies where the trimethoprim marker and pFLPe2 had been lost. 
The ΔgbdR1, ΔgbdR2, and ΔsouR phenotypes were complemented by cloning each gene 
and ~250 bps of the upstream regulatory region into pUC18mini-TN7T-Zeo and 
integration into one of the two attTn7 sites in B. thailandensis (26, 27) (Table 2.S1). 
Appropriate control strains were generated by attTn7 integration with the empty 
pUC18mini-TN7T-Zeo vector (Table 2.S1). 
 
2.3.3 Growth assays.  
Growth assays were performed by starting overnight cultures in MOPS minimal 
media supplemented with 20 mM pyruvate and 5 mM glucose incubated at 37 oC (28). 
Cultures were diluted in MOPS media to an OD600 of 0.07 and 30 µL were used to 
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inoculate 470 µL of MOPS media supplemented with carbon sources as described in a 
flat bottom 48-well plate (Costar). These plates were incubated at 37 oC with agitation 
and OD600 measured using a Biotek Synergy 2 plate reader.  
 
2.3.4 Alignments and phylogenetic tree construction.  
Sequence alignments and phylogenetic analysis were preformed using MEGA 
version 6 (29). Amino acid sequences of the relevant GATRs were aligned using 
MUSCLE (30). The ftrA sequence, a GATR homolog from Escherichia coli, was 
included as an outgroup to root the phylogenetic tree.  
 
2.3.5 RNA-Seq.  
For RNA-Seq, wild type, ΔgbdR1, ΔgbdR2, and ΔgbdR1Δgbdr2 strains were 
streaked from frozen stocks onto LB agar plates and incubated overnight at 37 oC. These 
plates were used to inoculate 3 mL MOPS with 20 mM pyruvate and 5 mM glucose 
cultures which were incubated for 18 hours at 37 oC on a rotary wheel. To initiate the 
experiment, 1 mL of these cultures was added to 2 mL of pre-warmed MOPS with 30 
mM pyruvate or 2 mL MOPS with 30 mM pyruvate and 1.5 mM choline; resulting in 
final concentrations of 20 mM pyruvate and 1 mM choline. These cultures were 
incubated for four hours at 37 oC. Cells from 1.5 mL of culture were collected by 
centrifugation and the resultant pellets were resuspended in RNA Protect Bacteria 
Reagent (Qiagen) and incubated at room temperature for 10 minutes. Cells were collected 
by centrifugation and resuspended in 50 µL 10 mM Tris, 1 mM EDTA (TE) buffer with 3 
mg/mL lysozyme and incubated at room temperature for 5 minutes. To each of these 
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resuspensions, 1 µL 20 mg/mL proteinase K, 0.5 µL of 10% SDS, 1 µL of DNase I 
(RNase-free, Ambion), and 2 µL of 50 mM MgCl2 were added and samples were 
incubated for 5 minutes at room temperature.  RNA was then prepared using the Qiagen 
RNeasy kit according to the manufacturer’s instructions. Eluate from this purification 
was further treated with 11 µL 10x DNase I buffer and 2 µL DNase I (RNase-free, 
Ambion) and incubated at 37 oC for 20 minutes to remove contaminating DNA and re-
purified using the Qiagen RNeasy protocol with the optional on-column DNase I step. 
The resulting purified RNA was assessed for purity by PCR and quantified by 
bioanalyzer chip, depleted of 16S and 23S rRNA by using MICROBExpress™ Bacterial 
mRNA Enrichment (Ambion), and subsequently reassessed by Bioanalyzer (Agilent 
Technologies). RNA-Seq DNA libraries were prepared by the Vermont Cancer Center – 
College of Medicine Massively Parallel Sequencing Facility using an Illumina TruSeq 
Stranded Total RNA Library Prep Kit and were run on an Illumina Hi-Seq 1500 to 
generate single end reads. Read quality was checked with FastQC (31).  Samples were 
aligned to the B. thailandensis E264 chromosomes I (NC_007651) and II (NC_007650) 
using BWA (32), duplicate reads were marked using Picard (version 1.110; Broad 
Institute of MIT and Harvard, [http://broadinstitute.github.io/picard/]) , and gene counts 
were calculated using summarizeOverlaps from the GenomicRanges package (33) before 
differential expression was called using the DESeq package (34) in R (version 3.0.1; R 
Development Core Team, [https://www.r-project.org/])  with assistance from the 
University of Vermont College of Medicine Bioinformatics Shared Resource group. 
RNA-Seq data has been deposited in NCBI GEO under record GSE81652.  
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2.3.6 qRT-PCR to confirm RNA-Seq findings.  
Wild-type, ΔgbdR1, ΔgbdR2, and ΔgbdR1Δgbdr2 strains were grown and 
induced as described for the RNA-Seq experiment. RNA was extracted similarly to the 
RNA-Seq, except that a third DNase I treatment was performed using the Ambion DNA-
free kit (AM1906) as per the manufacturer’s protocol. cDNA was generated using 
Superscript IV First-Strand Synthesis System (Invitrogen) using 24 ng of RNA combined 
with the 5’-NSNSNSNSNS-3’ primer previously described (35).  qPCR was performed 
as described in Willsey et al. (36).  Briefly, 0.2x SYBR Green I nucleic acid gel stain 
(Thermo Fisher Scientific (TFS)) was used with Q5 High-Fidelity 2x master mix (NEB) 
and amplified using cycle conditions of 98 oC for two minutes, 98 oC for 20 seconds, 
annealing at 60 oC for 30 seconds, and extension at 72 oC for 20 seconds repeated by 
going back to the second step 39 times. Reactions were performed in technical duplicate 
and biological triplicate with RT primers designed for BTH_I1140 (rplU), BTH_II1869 
(gbdR1), BTH_II1861 (gbcA), BTH_II1853 (putative porin), BTH_II0968 (gbdR2), 
BTH_II0966 (cbcV), BTH_II0994 (souR), and BTH_II0996 (soxB). A dilution series was 
used to generate a standard curve for each primer set. Each reaction was normalized to its 
respective rplU value, and then induced values were divided by uninduced values to 
derive a fold effect value.  
 
2.3.7 Purification of GbdR1, GbdR2, and SouR.  
gbdR1, gbdR2, and souR were each cloned into the pMAL-C2X expression vector 
generating an N-terminal maltose binding protein tag. The constructs were transformed 
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into E. coli T7 Express, transformants selected on LB agar + 100 µg/mL carbenicillin, 
and positive colonies used to inoculate 20 mL cultures of LB + 100 µg/mL carbenicillin. 
After 18 hours, these cultures were used to inoculate  500 mL flasks of LB + 100 µg/mL 
LB carbenicillin, grown to an OD600 of 0.3, and induced for 4 hours at 30 oC with 500 
µM IPTG. Cells were collected by centrifugation. Cells were then washed, collected by 
centrifugation, and the resulting cell pellets were flash frozen in liquid nitrogen. Cell 
pellets were resuspended on ice in 10 mL of chilled chromatography and lysis buffer (20 
mM Tris pH 7.4, 500 mM NaCl, 20 mM imidazole, 1x HALT protease inhibitor (TFS)). 
10 µL DNase I was added to the resuspended cell pellet, and the mixture was incubated 
for 10 minutes on ice. The resuspended cells were lysed with a French cell press using 
three 1100 PSI passages and NP-40 was then added to a final concentration of 0.05%. 
The lysate was clarified by centrifugation for 15 minutes at 15,000 rpm at 4 oC. The 
supernatant was passed over a column containing 1 mL bed volume of amylose resin 
beads (NEB). The column was then washed with 10 mL of column buffer 300 (20 mM 
Tris pH 7.4, 300 mM KCl, 1 mM EDTA, 0.05% NP-40, 0.7 µL/mL β-mercaptoethanol), 
then 10 mL column buffer 150 (20 mM Tris pH 7.4, 150 mM KCl, 1 mM EDTA, 0.05% 
NP-40, 0.7 µL/mL β-mercaptoethanol). Protein was eluted in column buffer 150 
containing 10 mM maltose and twelve 300 µL fractions were collected. Fractions were 
analyzed by SDS-PAGE acrylamide gels stained with Coomassie. Since GATR proteins 
tend to precipitate at higher concentrations, fractions of lower concentration were pooled 
and dialyzed in Slide-A-Lyzer® Dialysis Cassette G2 (TFS) against 2 L column buffer 
150. Aliquots were flash frozen in liquid nitrogen and stored at -80 oC. 
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2.3.8 Electrophoretic mobility shift assays (EMSA).  
Biotinylated or unlabeled primers were used to generate DNA probes from 
appropriate templates containing the putative promoter regions using Q5® High Fidelity 
DNA polymerase (NEB), then subjected to QIAquick PCR Purification Kit (Qiagen) and 
quantified using a Nanodrop 1000 (TFS). 20 µL reactions were assembled using 2x 
binding buffer (10 mM Tris pH 7.4, 200 mM KCl, 2 mM EDTA, 2 mM DTT, 10% 
glycerol, and 200 µg/µL bovine serum albumin (37)), 5 ng/µL poly (dI-dC), 25-75 nM 
purified MBP-tagged protein, 1 nM biotinylated DNA probe, and optionally 20 nM 
unlabeled competitor DNA probe. Reactions were incubated in a 30 oC waterbath for 20 
minutes, then 5 µL 5x EMSA loading buffer (1x TBE, 20% glycerol, 0.01% xylene 
cyanol, 0.01% bromophenol blue) was added and samples were loaded onto a 5% 
acrylamide 0.5x TBE gel. Gels were run for 1 hour at 100 volts then transferred to a 
BioDyne-B nylon membrane (Pierce) for 1 hour at 80 volts in 0.5x TBE at 4 oC. DNA 
was crosslinked to the membrane using a UV Stratalinker 2400 (Stratagene) on the auto 
crosslink setting, and the biotin-labeled probe visualized using the Pierce LightShift 
Chemiluminescent EMSA Kit (TFS) and imaged on a ChemiDoc XRS+ molecular 
imager (Bio-Rad). Density of resulting bands was quantified using Quantity One software 
from Bio-Rad. 
 
2.3.9 Generation of reporter constructs and β-galactosidase assays.  
Yeast homologous recombination was used to replace the kanamycin resistance 
gene in the shuttle vector pMQ131 (38) (apaHA3) with the Tp resistance gene (dhrFII) 
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resulting in pAN1.  Yeast recombination was also used to replace the lacZα fragment 
with the full lacZYA operon resulting in pAN7.  The intergenic region between gbdR1 
and glyA, as well as truncations of this region, were ligated into the SphI site proximal to 
the lacZYA ribosomal binding site,  and transformants selected on LB agar + 100 µg/mL 
Tp at 37 oC. Tp resistant colonies were used to inoculate 3 mL MOPS media with 20 mM 
pyruvate, 5 mM glucose, and 100 µg/mL Tp, which were incubated for 48 hours at 37 oC. 
Cells from these cultures were collected by centrifugation at 13000 rpm for 2 min at 
room temperature, washed with 1 mL MOPS media, collected again by centrifugation 
and the pellets resuspended in MOPS media. 30 µL of this resuspension was used to 
inoculate each well in a 48-well plate that contained  470 µL MOPS media with 20 mM 
pyruvate and with or without 1 mM choline. These cultures were incubated for 48 hours 
at 37 oC on an orbital shaker at 170 rpm in a humidified chamber. The extended induction 
time was shown to be necessary for detectable β-galactosidase activity empirically in our 
hands, and as indicated by Kang et al. (39). β-galactosidase activity was quantified as 
previously described (21).  
 
2.4 Results 
2.4.1 Organization of predicted B. thailandensis orthologs of P. aeruginosa choline 
catabolic genes.  
The choline catabolic pathway and its regulation in P. aeruginosa have been 
described previously (20, 40). Briefly, in P. aeruginosa the TetR family transcription 
factor BetI represses expression of betIBA and is derepressed by choline, allowing 
production of the BetA and BetB enzymes that to convert choline into GB (41-43). The 
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GATase1-like AraC-family transcription regulator (GATR) GbdR responds to GB and 
dimethylglycine (DMG) by inducing expression of catabolic genes including gbcA-B, the 
dgc operon (PA5376, PA5377, dgcA, dgcB, PA5400, PA5401), and the sarcosine oxidase 
genes, which together contribute to the sequential demethylation of GB to DMG, 
sarcosine, and finally glycine (Fig 2.1A,C). SouR, also a GATR, controls transcriptional 
induction of the sarcosine oxidase genes in response to sarcosine (36).  Homologs of betI 
and betBA in B. thailandensis have been described previously (39).  
  Sequence analysis revealed two likely GbdR orthologs in B. thailandensis, 
BTH_II1869 (gbdR1) and BTH_II0968 (gbdR2), with strong amino acid sequence 
homology to P. aeruginosa GbdR (48.2% and 47.0% identity and 75.5% and 71.3% 
similarity, respectively, using BLOSUM50 along the entire protein length). Alignments 
of the characterized P. aeruginosa GATRs (ArgR, CdhR, SouR), and their putative B. 
thailandensis orthologs, revealed that the B. thailandensis GbdR orthologs were more 
similar to each other than to P. aeruginosa GbdR or any other GATRs (Fig 2.1B). This 
suggested that they might also have similar functions or play separate roles within the 
same catabolic pathway. The presence of a more distantly related GATR divergently 
transcribed from the sarcosine oxidase operon (Fig 2.1B, C), led us to predict that 
BTH_II0994 was a functional ortholog of P. aeruginosa SouR, though the phylogenetic 
tree suggests that they share no recent paralogy.   
  On the P. aeruginosa chromosome, gbdR is located one gene away from the 
cbcXWV transport genes (Fig 2.1C), previously implicated in the transport of choline and 
its immediate metabolites into the cytosol from the periplasm (44), and adjacent to the 
sdaB gene known to participate in the pathway (45). In B. thailandensis, gbdR1 is located 
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adjacent to a putative operon containing the bulk of predicted orthologous genes 
encoding enzymes needed for GB catabolism to sarcosine, while gbdR2 is present within 
a locus containing the putative cbcXWV orthologs (Fig 2.1C). The homology of GbdR1 
and GbdR2 with P. aeruginosa GbdR, combined with their chromosomal locations 
adjacent to genes involved in choline metabolism, strongly suggested that both 
transcription factors were involved in the regulation of this pathway. The synteny of the 
gbdR1 and gbdR2 loci in B. thailandensis E264 is conserved throughout the various 
clades of Burkholderiales, including species such as B. pseudomallei, B. mallei, B. 
cenocepacia, B. ambifaria, and B. multivorans. This conservation in synteny suggests 
that both GbdR1 and GbdR2 play roles in the regulation of choline metabolism in 
Burkholderia.  
 
2.4.2 gbdR1 and gbdR2 contribute differentially to choline catabolism.  
B. thailandensis, like P. aeruginosa (46), can use choline as a sole source of 
carbon and/or nitrogen (Fig 2.2A). Based on our predictions of gbdR1 and gbdR2 
involvement in choline metabolism we tested the ability of each single deletion strain and 
the double deletion strain to grow using choline as a sole carbon source. Wild type B. 
thailandensis grows on choline as a sole carbon source, while a ΔgbdR1 or 
ΔgbdR1Δgbdr2 strain cannot (Fig 2.2A, right side). Deletion of gbdR2 alone resulted in 
reduced growth on choline as a sole carbon source (Fig 2.2A, right side). On plates, none 
of the manipulations appeared to alter growth on pyruvate as a sole carbon source (Fig 
2.2A, left side). The impaired but visible growth of the ΔgbdR2 strain led us to examine 
the growth kinetics of these strains on choline and its downstream metabolites GB and 
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DMG. Deletion of gbdR2 results in slower growth than wild type on choline, GB, and 
DMG, comprised of both an extended lag phase and a lower growth rate during 
exponential phase (Fig 2.2B). Deletion of these transcription factors did not substantially 
alter growth kinetics using pyruvate as a sole carbon source, but did alter maximal yield 
in liquid culture in the double deletion strain (Fig 2.2B), although this difference was not 
apparent on solid media (Fig 2.2A, left side). The ΔgbdR1 and ΔgbdR1Δgbdr2 strains 
showed no measurable growth on any of the choline-related metabolites tested within 100 
hours.  
  Integration of gbdR1 at the attTn7 site restored growth of a ΔgbdR1 strain on 
choline, GB, and DMG (Fig 2.3A). Growth in GB and DMG was very similar to wild 
type, while growth of the complement strain on choline exceeded that of wild type on 
choline (Fig 2.3A).  Similarly, integration of gbdR2 at the attTn7 site restored growth of a 
ΔgbdR2 strain on choline-related carbon sources and resulted in more rapid growth than 
in wild type for choline, GB, and DMG (Fig 2.3B). We also tested complementation of 
ΔgbdR1ΔgbdR2 with either gbdR1 or gbdR2. The ΔgbdR1Δgbdr2 attTn7::gbdR1 strain 
was able to grow on choline as a sole carbon source in MOPS minimal media, though not 
at wild type levels, whereas ΔgbdR1Δgbdr2 attTn7::gbdR2 was not capable of growth on 
choline (Fig 2.S1). Taken together, these data suggest that gbdR1 and gbdR2 regulate the 
choline catabolic pathway, with gbdR1 absolutely required and gbdR2 playing an 
accessory role.   
 
2.4.3 GbdR1 and GbdR2 regulate transcription of genes involved in the choline 
catabolic pathway.  
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   To identify the GbdR1 and GbdR2 regulons, we exposed our deletion strains to 
minimal media with pyruvate as a primary carbon source and with or without 1 mM 
choline, and analyzed the transciptomes by RNA-seq. Exposure of wild-type B. 
thailandensis to choline resulted in 57 transcripts being induced or repressed more than 
2.3 fold, many predicted to be involved in quaternary amine catabolism and transport 
(Table 2.1). A prominent cluster of induced genes from BTH_II1868 to BTH_II1853 
includes orthologs to the P. aeruginosa glyA (BTH_II1868), the dgc operon 
(BTH_II1867, BTH_II1866, BTH_II1865, BTH_II1864, BTH_II1863, and BTH_II1862), 
gbcA (BTH_II1861), gbcB (BTH_II1860), and betX (BTH_II1859).  Based on these 
predictions, the putative operon consisting of glyA to BTH_II1858 (Fig 2.1C) encodes the 
genes likely to be responsible for the breakdown of GB to sarcosine. Also induced was a 
nearby predicted operon consisting of BTH_II1855- BTH_II1853, encoding likely 
orthologs of P. aeruginosa betC, cosX, and a predicted porin.  Another GATR, 
BTH_II0994, and the divergently transcribed operon consisting of BTH_II0995 (sdaA-2), 
BTH_II0996 (soxB), BTH_II0997 (soxD), BTH_II0998 (soxA), BTH_II0999 (soxG), and 
BTH_II1000 were also induced and we hypothesized that these are the B. thailandensis 
souR and the sarcosine oxidase genes responsible for the breakdown of sarcosine to 
glycine (36).  
  Homologs of cbcXWV in P .aeruginosa, an operon important for the transport of 
choline, are present in B. thailandensis and are also induced by choline. The gbdR2 gene 
is situated in this operon, between BTH_II0967 (cbcW) and BTH_II0969 (cbcX). The 
aforementioned genes are induced by choline in the wild type strain, but are not in either 
ΔgbdR1 or ΔgbdR1Δgbdr2, suggesting an absolute requirement of gbdR1 in the 
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regulation of these genes. Cells lacking gbdR2 express all of the genes in the major 
catabolic operon, glyA-BTH_II1858, in response to choline but to a lower level than the 
wild type. Interestingly, the relative induction of the transcripts in the transport operon 
containing gbdR2 are unaffected by the absence of gbdR2, suggesting that there is no 
autoregulation of the gbdR2 operon. 
  To confirm our RNA-Seq results, we preformed qRT-PCR on a subset of induced 
genes and the transcription factors of interest, normalized to rplU transcript levels (Fig 
S2). The wild type B. thailandensis response to choline in our qRT-PCR experiment 
reflected our RNA-Seq results. gbcA, cbcV, and soxB are all induced in response to 
choline, suggesting overall induction of their putative operons. The qRT-PCR data also 
shows that the GATRs gbdR1 and souR transcripts were slightly induced in response to 
choline while gbdR2 was induced at a higher level. This slight increase in gbdR1 
expression observed may be negligible and therefore it is unclear if induction of gbdR1 is 
a mechanism by which GbdR2 regulates choline catabolism. Overall, we interpret the 
matching trends in expression between the RNA-Seq and qRT-PCR experiments as a 
validation of our findings. 
 
2.4.4 The glyA promoter is induced by choline under the control of GbdR1 and 
GbdR2.  
pAN27 is a reporter plasmid containing the full 408 bp intergenic region between 
gbdR1 and glyA, such that the glyA promoter drives lacZYA expression. This reporter was 
used to assess the transcriptional control of the glyA promoter. This putative promoter 
likely controls the expression of BTH_II1868 to BTH_II1857 and thus governs the bulk 
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of genes needed to convert GB to sarcosine. In a B. thailandensis wild-type background, 
pAN27 lacZ expression is induced by choline, GB, and DMG, but not ethylcholine (Fig 
2.4A). Ethylcholine is a non-metabolizable inducer of GbdR-dependent transcription in 
P. aeruginosa (40). The inability of this choline analog to elicit similar effects in a 
GbdR/GbdR2 dependent promoter suggests specificity differences between GbdR and 
GbdR1 or GbdR2, a metabolite transport difference, or a difference in the specificity of 
choline oxidase. No β-galactosidase activity was detected when pAN27 in B. 
thailandensis was induced using 1 mM sarcosine, similar to findings in P. aeruginosa for 
gbdR-dependent induction of choE, a choline esterase (40), or for the phospholipase plcH  
(47, 48) (data not shown). 
  ΔgbdR1, ΔgbdR2, and ΔgbdR1Δgbdr2 deletion strains carrying pAN27 failed to 
show significant choline-induced β-galactosidase induction when compared to the wild 
type control (Fig 2.4B), and basal expression was also low. This suggests that both gbdR1 
and gbdR2 are required for robust induction of the glyA promoter. We would have 
predicted that ΔgbdR2 would produce some β-galactosidase activity in response to 
choline, as ΔgbdR2 can use choline as a sole carbon source (Fig 2.2). The incongruity 
may be due to the unusually long time it takes to observe β-galactosidase activity in B. 
thailandensis, combined with the long delay in growth of ΔgbdR2 on choline (Fig 2.2). 
As a follow-up experiment, we transformed pAN27 into a ΔsouR to determine if SouR is 
required for glyA promoter induction in B. thailandensis (Fig 2.S3). β-galactosidase 
activity in ΔsouR in response to choline is robust, higher than in wild type, potentially 
due to blockage of the catabolic pathway and subsequent buildup of intermediate 
metabolites. This indicates that SouR is not required for induction of glyA, but could also 
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point to positive feedback control between sarcosine metabolism and regulation of 
upstream steps. 
  Reporter plasmids derived from pAN27 with progressively smaller portions of the 
intergenic region between gbdR1 and glyA were produced (-340, -251, -147, -85 with 
respect to the glyA putative translational start site) in order to map the choline-dependent 
portion of the glyA regulatory region. Exposure of cells containing these constructs to 
choline resulted in choline-dependent induction of β-galactosidase activity for -340 and -
251, but not -147 or -85 (Fig 2.4C). This suggests that the region from -251 bp to the 
translation start site of glyA is necessary for a response to choline.  
 
2.4.5 GbdR1 and GbdR2 bind directly to the glyA promoter.  
N-terminally tagged MBP-GbdR1 and MBP-GbdR2 were produced and assayed 
by EMSA using biotinylated DNA probes representing sections of the intergenic region 
between gbdR1 and glyA. Probe 1 is 216 bp covering the -320 to -104 bp region with 
respect to the glyA translational start site, while probe 2 is 178 bp covering the -160 to 
+18 region. MBP-GbdR1 could bind probe 1 in a concentration-dependent manner, and 
binding to biotinylated probe 1 could be significantly competed with unlabeled probe 1 
(Fig 2.5A). MBP-GbdR1 did not interact with probe 2 (right-most lane, Fig 2.5A), and 
unlabeled probe 2 was markedly less able to compete with MBP-GbdR1 binding to 
labelled probe 1. These data support a GbdR1 binding site within probe 1.  Similar results 
were obtained using MBP-GbdR2, which was also able to bind to probe 1, not probe 2, 
and could be similarly competed from labeled probe 1 using unlabeled probe 1 (Fig 
2.5B), and again much less so with the unlabeled probe 2. The shift produced by MBP-
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GbdR2 consists of multiple bands that are likely the result of oligomerization. Results 
using 6xHis-N-terminally tagged versions of GbdR1 and GbdR2 produced the same 
results and banding patterns, although the solubility of the 6-His version was much lower 
than the MBP fusions (data not shown). These results provide evidence that both GbdR1 
and GbdR2 can both bind to the glyA promoter. When combined with results from our 
reporter assays (Fig 2.4), we infer that the binding site for GbdR1 and GbdR2 is likely to 
be contained within the -251 to -160 bp region with respect to the glyA translational start 
site. As we have previously shown for P. aeruginosa GbdR and SouR, addition of their 
presumptive ligand did not impact binding to DNA (data not shown). 
 
2.4.6 B. thailandensis SouR regulates sarcosine metabolism.  
Sarcosine is a downstream metabolite of choline and orthologs of P. aeruginosa 
sarcosine oxidase genes were identified in our RNA-Seq results (Table 2.1, Fig 2.1C). P. 
aeruginosa uses sarcosine as a sole carbon and nitrogen source and this is regulated by 
the transcription factor, SouR (36). While B. thailandensis can use choline as a sole 
carbon or sole carbon and nitrogen source, B. thailandensis is unable to grow on 
sarcosine as a sole carbon source, or as a sole carbon and nitrogen source (Fig 2.S4). We 
hypothesize that the ability of B. thailandensis to transport extracellular sarcosine may be 
limited in comparison with P. aeruginosa, and the rate of import is insufficient to support 
growth as a sole carbon source. It is, however, able to utilize sarcosine as a sole nitrogen 
source when pyruvate is available as a primary carbon source, and does so in a SouR 
dependent manner (Fig 2.6A). Deletion of gbdR1 or gbdR2 has no major effect on the 
ability of B. thailandensis to utilize sarcosine as a nitrogen source, but ΔsouR does show 
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a reduced level of growth.  
   BTH_II0994 is a GATR divergently transcribed from the sarcosine oxidase 
operon and we hypothesized that it might be functionally orthologous to souR in P. 
aeruginosa (Fig 2.1C), despite BTH_II0994 and SouR not sharing a high degree of 
similarity when compared to the other GATR orthologous pairs (Fig 2.1B). To test if 
BTH_II0994 was a functional souR, we generated a B. thailandensis ΔsouR strain and 
used it to determine if souR is required for growth on choline. ΔsouR fails to grow on 
choline, GB, or DMG as a sole carbon source (Fig 6B). This is contrary to regulation in 
P. aeruginosa, where choline, GB, and DMG can still be used as sole carbon sources for 
growth in the absence of souR, although at a diminished growth rate (36). This result also 
suggests that GbdR1 and GbdR2 are insufficient to cause induction of the sarcosine 
oxidase genes by themselves or together, contrary to the regulation scheme in P. 
aeruginosa (Fig 2.1A). This phenotype can be complemented by chromosomal 
integration of souR at an attTn7 site under the control of its native promoter (Fig 2.6B).  
  MBP-SouR was produced and its DNA binding assessed using EMSA with a 
biotinylated 230 bp oligo designated probe 3, covering the region -208 to +22 base pairs 
relative to the putative translation start site of sdaA-2, the first gene in the likely sarcosine 
oxidase operon of B. thailandensis. MBP-SouR was able to bind the biotinylated probe 3, 
but not the probe 2 negative control. The binding of MBP-SouR to Biotinylated probe 3 
could be competed off with unlabeled probe 3, but not unlabeled probe 2, suggesting that 
this interaction is specific (Fig 2.6C). The binding of MBP-SouR to this putative 
promoter region coupled to the phenotype of the ΔsouR strain suggests that SouR is 
responsible for the regulation of the sarcosine oxidase genes in B. thailandensis.  
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2.5 Discussion 
 The ability to utilize GB as a compatible solute, providing protection against 
osmotic and other stresses without creating significant disruption of normal cell 
processes, is nearly ubiquitous among bacteria, however the ability to catabolize GB is 
not as widespread (49). B. thailandensis and other species in this genus possess the 
enzymes for utilizing choline and its metabolites as carbon and nitrogen sources, taking 
advantage of this widely available biomolecule as befits their description as metabolically 
adaptable bacteria. P. aeruginosa, another soil-dwelling and metabolically adaptable 
microorganism, shares this ability and was our original model for the study of the GB 
catabolic pathway and its regulation (20). B. thailandensis and P. aeruginosa inhabit 
similar environments, possess similarly sized genomes, encode diverse metabolic 
pathways, and are thus considered to have similar generalist strategies, despite B. 
thailandensis and P. aeruginosa belonging to the β-proteobacteria and ɣ-proteobacteria 
classes, respectively. The metabolic enzymes in the choline catabolic pathway are well 
conserved and the orthologous genes in different species are readily identifiable. 
However, the identification of gbdR2 and the alternate gene organization in B. 
thailandensis prompted us to ask if the choline regulatory network was as well conserved. 
We show here that B. thailandensis uses an alternate regulatory solution to control this 
pathway compared to P. aeruginosa. Both B. thailandensis and P. aeruginosa can store 
pools of GB (17) and metabolize it as a carbon and nitrogen source, therefore the 
different regulatory networks suggest evolution of alternate strategies to control the 
decision to store or catabolize.  
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 Although the data presented here indicates that choline catabolism is regulated 
differently in B. thailandensis than in P. aeruginosa (Fig 1A), the basic components of 
the pathway are conserved and thus the overall scheme of the pathway is the same. In 
both organisms, choline catabolism begins with choline-dependent de-repression of the 
catabolic genes responsible for the conversion of choline to GB, betBA, mediated by the 
choline-sensing TetR-family transcription factor BetI. These genes have been described 
previously (41), and evidence suggests they function in B. thailandensis as they do in P 
.aeruginosa (39). In P. aeruginosa GB is subsequently metabolized to DMG by GbcA 
and GbcB heterodimer (50, 51), and from DMG to sarcosine by enzymes in the dgc 
operon (52), all under the regulation of GbdR (20). In B. thailandensis the same 
enzymatic steps are under the control of GbdR1, modulated by GbdR2.  Sarcosine is then 
demethylated to glycine by components of the sarcosine oxidase operon and glyA1, 
controlled in tandem by GbdR and SouR in P. aeruginosa, and controlled separately by 
SouR, and GbdR1 and GbdR2 respectively in B. thailandensis as described below.  
 In this study we determined that both GbdR1 and GbdR2 participate in the 
regulation of GB catabolism, and characterized their regulons. Both regulators are 
GATRs with strong amino acid sequence similarity to GbdR in P. aeruginosa, and 
deletion strains confirmed that both play roles in the regulation of choline catabolism and 
catabolism of its downstream metabolites (Fig 2, 3). Combining the transcriptional data 
with the growth phenotypes of the deletion strains supports gbdR1 as required for 
expression of the major catabolic cluster of genes and the transport operon that includes 
gbdR2. gbdR2, on the other hand, is important for a robust response to choline, enhancing 
expression of many genes required to import and catabolize choline and its metabolites, 
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particularly the major catabolic cluster (Fig 2.1C, Table 2.1). The operon containing 
gbdR2 and the putative cbcWVX orthologs, is likely regulated solely by GbdR1. Although 
the presence of gbdR1 is sufficient for growth (Fig 2.2A-B), reporter assays and growth 
studies showed that both gbdR1 and gbdR2 are required for a robust transcriptional 
response (Fig 2.4A) and growth on choline (Fig 2.2). In agreement with promoter 
mapping results (Fig 2.4C), EMSA data suggests that GbdR1 and GbdR2 likely share a 
similar binding site, raising the question of whether or not they compete for the same 
binding site or act synergistically. A possibility is that GbdR1 and GbdR2 possess 
differential DNA binding Kd values that result in differential response to choline and its 
metabolites under different physiological conditions.   
  In addition to gbdR1 and gbdR2, our transcriptome analysis revealed a third 
GATR induced in response to choline, BTH_II0994, which we confirmed as a functional 
souR ortholog in B. thailandensis. In P. aeruginosa, SouR regulates the expression of the 
sarcosine oxidase catabolic operon, the components of which are responsible for 
converting sarcosine to glycine (36). SouR in B. thailandensis is less similar to GbdR, 
GbdR1, and GbdR2 than is the SouR in P. aeruginosa (Fig 1B). B. thailandensis souR 
(BTH_II0994) is divergently transcribed from the sarcosine oxidase operon, whereas P. 
aeruginosa souR (PA4184) is distantly located and part of a two gene operon. These 
factors suggest a divergence in how souR was acquired or evolved in both organisms. 
The inability of B. thailandensis to grow on sarcosine as a sole carbon source was 
surprising given that choline is readily catabolized and the enzymes for sarcosine 
catabolism are expressed (Fig 2.6A). We found that souR in B. thailandensis is required 
for sarcosine catabolism, unlike in P. aeruginosa where GbdR can induce the sarcosine 
60 
 
oxidase operon in the absence of souR (36). The complementation and EMSA for the 
sarcosine oxidase operon putative promoter provides further evidence that BTH_II0994 is 
indeed the functional souR ortholog in Burkholderia (Fig 2.6B, C). It is not clear if SouR 
is capable of autoregulation of souR or if GbdR1 controls its expression directly.  
  GbdR1, GbdR2, and SouR are all GATRs implicated in the regulation of genes 
involved in the catabolism of quaternary amines or their metabolites. GATRs are 
members of the AraC transcription factor family, grouped by their canonical C-terminal 
DNA binding domain, but unlike classic AraC proteins they contain a GATase1-like N-
terminal domain. The GATase1-like domain is characterized by its homology to class-I 
glutamine amidotransferases, which bind glutamine or ammonia and participate in the 
amidation/deamidation reaction (53, 54). Many of the GATR N-termini, notably 
excluding SouR in P. aeruginosa, also retain a bioinformatically identified cysteine 
residue that would be part of the functional catalytic triad of GATase1 family enzymes. 
The N-terminal domain of AraC proteins is typically involved in ligand binding and 
dimerization, which is a characteristic important for their functionality, and dimerization 
is often affected by the binding of ligand (55). P. aeruginosa possesses other GATRs 
implicated in the catabolism of N-substituted amines including argR, the regulator of 
arginine catabolism (56), and cdhR, the regulator of carnitine catabolism (20). Putative 
argR and cdhR orthologs are also present in B. thailandensis (unpublished data). We 
hypothesize that the GATase1-like domain has been combined with the AraC-style DNA 
binding domain to enable detection of charged amine-containing compounds and that 
GATRs as a whole may represent a sub-family of transcription factors that regulate 
metabolism of accessory nitrogen sources, including choline and its metabolites.  
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  The transport of choline and derivative molecules also appears to be handled 
differentially between B. thailandensis and P. aeruginosa based on genomic information. 
P. aeruginosa possesses an array of BCCT and ABC-family transporters that have been 
implicated in choline and GB transport that are effective under different osmotic 
conditions or primarily utilized when choline is in such abundance that it can be used as a 
carbon or nitrogen source (44). B. thailandensis possesses fewer transporters, with only 
one putative homolog of the BCCT-family transporter (BTH_II1109), compared to the 
three in P. aeruginosa (betT1, betT2, betT3). B. thailandensis possess a putative amino 
acid permease, BTH_II1858, as part of the major GB catabolic operon with no obvious 
ortholog in P. aeruginosa. The placement of BTH_II1858 and conserved synteny among 
Burkholderia suggests a role as a transporter for choline or its derivatives, but there is no 
functional evidence as of yet. Some Pseudomonads have a putative ortholog of 
BTH_II1858 identified as an ethanolamine transporter, ethanolamine being similar to 
choline in its role as a head group for phospholipids, suggesting the possibility of a link 
to general fatty acid metabolism.  Both B. thailandensis and P. aeruginosa also possess 
orthologs of the choline/GB transporter, opuC that was described in P. syringae and 
found to function under hyperosmolar conditions (57). B. thailandensis orthologs to 
many of the P. aeruginosa periplasmic binding proteins that mediate ABC-transporter 
dependent import of quaternary amines (cbcX (BTH_II0969), caiX (BTH_II1849), betX 
(BTH_II1859), cosX (BTH_II1853)), but these are apparently not sufficient for efficient 
sarcosine transport (Fig 2.S4). This result is perhaps not surprising as limited current data 
suggest that sarcosine does not compete well with choline for these transporters in P. 
aeruginosa (58). To date the sarcosine transporter has not been identified, and the 
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functional differences between P. aeruginosa and B. thailandensis for sarcosine 
utilization in the background of a similar metabolic pathway may provide a platform for 
identification of this transporter.  
 In this study we have identified an alternative model for the regulation of choline 
catabolism that incorporates multiple GATRs and examined their respective regulons. 
The conservation of gbdR1 and gbdR2 throughout the Burkholderia genus suggests that 
differences in regulation of choline catabolism outlined here represent a model that can 
be extrapolated to the more pathogenic strains, as well those strains associated with the 
rhizosphere. Contrasting the models of choline catabolism in B. thailandensis and P. 
aeruginosa will serve as a useful tool to probe the remaining unanswered questions 
concerning the pathway.  
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2.7 Chapter 2 Figures 
 
Figure 2.1 - Comparison of B. thailandensis and P. aeruginosa choline metabolism and 
associated regulators.  
(A) Model of choline catabolic regulation in P. aeruginosa (left) and B. thailandensis 
(right). (B) Phylogenetic tree of relevant GATRs in B. thailandensis and P. aeruginosa 
rooted to FtrA, a GATR present in E. coli. (C) Diagram of the chromosomal context of 
gbdR, gbdR1, gbdR2, souR and major catabolic genes for the catabolism of GB and 
subsequent metabolites for B. thailandensis and P. aeruginosa.  
 
Figure 2.2 - Deletion of gbdR1 and gbdR2 result in altered growth on choline and its 
metabolites as sole carbon sources.  
(A) Growth of B. thailandensis deletions strains on MOPS minimal media agar plates 
supplemented with either 20 mM pyruvate or 20 mM choline and incubated at 37 oC for 
72 hours. Δgbdr1 and ΔgbdR1ΔgbdR2 fail to grow on choline while ΔgbdR2 exhibits less 
growth. (B) Growth curves reveal the inability of Δgbdr1 and ΔgbdR1ΔgbdR2 to grow on 
choline or its metabolites while ΔgbdR2 exhibits a slow-growth phenotype on choline, 
glycine betaine, and dimethylglycine. Growth curves are representative of at least three 
experiments per condition at each time point, each with biological triplicates, and the 
error bars represent standard deviation. 
 
Figure 2.3 - The growth phenotypes of ΔgbdR1 and ΔgbdR2 can be complimented.  
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(A) Complementation of ΔgbdR1 at attTn7 with gbdR1 and its putative promoter results 
in restoration of ability to grow on choline and its metabolites. (B) Complementation of 
ΔgbdR2 at attTn7 with gbdR2 results in an increased growth rate on choline and its 
metabolites, surpassing the growth rate of wild type. Growth curves are representative of 
at least three experiments per condition at each time point, each with biological 
triplicates, and the error bars represent standard deviation. 
 
Figure 2.4 - The glyA promoter is induced by choline and its metabolites under the 
combined control of gbdR1 and gbdR2.  
(A) β-galactosidase activity from pAN27 is induced in the presence of choline and its 
metabolites, but not pyruvate. (B) gbdR1 and gbdR2 are both required for significant β-
galactosidase induction in the presence of choline. (C) Promoter truncations of the glyA 
promoter reveal that the critical region is located between -147 and -340 with respect to 
the predicted translational start site of glyA. In each case, data presented represents the 
standard error of the mean determined from three independent experiments, each with 
three technical replicates. Statistical notation in panel (A) based on one-way ANOVA 
with Dunnett’s post-test using the pyruvate group as the comparitor, while (B) & (C) 
were analyzed by two-way ANOVA with Sidak’s post-test comparing with vs. without 
choline. Abbreviations and symbols: pyruvate (Pyr), choline (Cho), glycine betaine (GB), 
dimethylglycine (DMG), ethylcholine (EtCho), not significant (n.s.), p < 0.05 (*), p < 
0.01 (**), p < 0.001 (***), p < 0.0001 (****).  
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Figure 2.5 - MBP-GbdR1 and MBP-GbdR2 bind to the regulatory region of the major 
GB catabolic operon (BTH_II1868-BTH_II1858).  
(A) MBP-GbdR1 binds to biotin-probe 1 in a dose dependent manner (lanes 3-5). The 
interaction is specific as it does not bind to biotin-probe 2 (lane 8) and can be competed 
off biotin-probe 1 with unlabeled probe 1 (lane 6 compared to lane 4, 17.2% shift versus 
75.2% shift respectively), but less so with unlabeled probe 2 (lane 7 compared to lane 4, 
51.5% shift versus 75.2% shift respectively). (B) MBP-GbdR2 also binds specifically to 
probe 1 in a dose dependent manner (lanes 3-5) while failing to bind to biotin-probe 2 
(lane 8). The binding between MBP-GbdR2 and biotin-probe 1 is also specific, as it can 
be competed by unlabeled probe 1 (lane 6 compared to lane 4, 4.3% shift versus 16% 
respectively) but less so by unlabeled probe 2 (lane 7 compared to lane 4, 7.7% shift 
versus 16% respectively).   
 
Figure 2.6 - SouR is a critical regulator of the choline catabolic pathway.  
(A) B. thailandensis can utilize choline as a nitrogen source. Strains were grown on 20 
mM Pyruvate with either 5 mM or choline (C) or sarcosine (S) for 72 hours at 37 oC. 
ΔgbdR1, ΔsouR and ΔgbdR1ΔgbdR2ΔsouR were significantly diminished in their ability 
to utilize choline as a nitrogen source. ΔgbdR2 utilized both choline and sarcosine as a 
nitrogen source at similar levels to wild type. ΔsouR used sarcosine as a nitrogen source 
at reduced rates compared to the wild type. OD600 measurements were normalized to 
basal growth without a nitrogen source and then normalized to wild type and represented 
as percent growth. (B) Deletion of souR prevents B. thailandensis from using choline as a 
carbon source. Complementation of souR at an attTn7 site with souR, under the control of 
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its putative native promoter, restores the ability of B. thailandensis to utilize choline and 
its metabolites as carbon sources. Strains were grown with either 40 mM pyruvate (P), 
choline (C), GB (G), or DMG (D) as a sole carbon source in MOPS minimal media for 
72 hours at 37 oC. (C) MBP-SouR binds to the putative promoter of the sarcosine oxidase 
operon represented by biotin-probe 3 in a dose dependent manner (lanes 3-5). The 
interaction is specific, as MBP-Sour does not bind to biotin-probe 2 (lane 8) and can be 
competed off by unlabeled probe 3 (lane 6 compared to lane 4, 22% shift versus 37.1% 
respectively), but not by unlabeled probe 2 (lane 7 compared to lane 4, 38.2% shift versus 
37.1% respectively). Data in panels (A) & (B) are averaged from three experiments each 
with three biological replicates and error bars represent SEM. These data were both 
analyzed by two-way ANOVA with Tukey’s post-test testing for strain effect for each 
carbon source separately, not comparing the carbon sources. For (A), except for ΔgbdR2, 
all choline changes are different from WT and are not noted. Only the sarcosine 
comparisons different from WT are noted. For (B), pyruvates were not significantly 
different, but all other comparisons were except WT vs. the mutant in dimethylglycine. p 
< 0.01 (**), p < 0.001 (***). 
 
Figure 2.S1 – Complementation of ΔgbdR1ΔgbdR2 with gbdR1 or gbdR2.  
Complementation of ΔgbdR1ΔgbdR2 with gbdR1 alone is able to restore the ability of B. 
thailandensis to utilize choline as a carbon source, but gbdR2 alone is unable to 
complement the metabolic deficiency. Data shown are averaged from three experiments 
each with three biological replicates and error bars represent SEM. Data analyzed by two-
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way ANOVA with Dunnett’s post-test using the double deletion mutant as the 
comparator making comparisons within each time point. The asterisks indicate p < 0.01. 
 
Figure 2.S2 – Validation of RNA-Seq experiments. 
Validation of RNA-Seq experiments by qRT-PCR supports the findings of the RNA-Seq 
experiment. RNA-Seq values were normalized within DEseq based on library size while 
the RT-qPCR values were normalized to the rplU transcript levels. Both data sets are 
expressed here as fold change in expression scaled to their own respective y-axes. 
 
Figure 2.S3 – pAN27 is still responsive to choline in ΔsouR. 
pAN27 is still responsive to choline in ΔsouR, and β-galactosidase activity seems to be 
induced to even higher levels as compared to wild type. This suggests that SouR is not 
required for the induction of glyA promoter. Data shown are averaged from three 
experiments each with three biological replicates and error bars represent SEM. 
 
Figure 2.S4 – Usage of choline and sarcosine as sole carbon or nitrogen sources. 
B. thailandensis can utilize choline as either a carbon or carbon and nitrogen source. B. 
thailandensis is unable to utilize sarcosine as a carbon or carbon and nitrogen source, 
unlike P. aeruginosa. Strains were grown in MOPS minimal media or MOPS minimal 
media without NH4, with either 40 mM or choline (C) or sarcosine (S) for 72 hours at 37 
oC. Data shown are averaged from three experiments each with three biological replicates 
and error bars represent SEM. 
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2.8 Chapter 2 Tables 
Table 2.1 – Transcript changes of B. thailandensis in response to choline. 
Table 2.S1 – Strains and plasmids. 
Table 2.S2 – Primers used in study. 
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Table 2.1 Transcript changes of B. thailandensis in response to choline.  
  Linear fold change in transcript over pyruvate 
alonea: 
Locus ID Geneb wt ΔgbdR1 ΔgbdR2 ΔgbdR1 
ΔgbdR2 
BTH_I0192  -2.6 NCc NC NC 
BTH_I0393  -4.8 NC NC NC 
BTH_I0394  -5.1 NC NC NC 
BTH_I0395  -8.3 NC NC NC 
BTH_I0396  -4.3 NC NC NC 
BTH_I0398  -3.9 NC NC NC 
BTH_I0687  23.8 NC 10.5 NC 
BTH_I0688  19.3 NC NC NC 
BTH_I0698  11.3 NC NC NC 
BTH_I0700  12.0 NC NC NC 
BTH_I0866  5.8 5.3 NC NC 
BTH_I0959  -2.6 NC -5.3 -5.0 
BTH_I1406  -2.3 NC -4.4 NC 
BTH_I1620  5.7 NC 4.4 4.4 
BTH_I1621  61.2 NC 18.3 NC 
BTH_I1622  52.7 NC 9.7 NC 
BTH_I1623  40.0 NC 9.3 NC 
BTH_I1624  43.7 NC 5.0 NC 
BTH_I1625  5.5 NC NC NC 
BTH_I3016  -2.8 NC -3.6 -3.4 
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BTH_I3017  -3.1 NC -4.0 -3.9 
BTH_II0001  5.4 NC 9.0 6.5 
BTH_II0643  2.4 NC NC NC 
BTH_II0694  -3.4 NC -2.4 NC 
BTH_II0695  -2.6 NC NC NC 
BTH_II0964  2.9 NC NC NC 
BTH_II0966 cbcV 45.4 NC NC NC 
BTH_II0967 cbcW 94.0 NC NC NC 
BTH_II0968 gbdR2 81.7 NC NC NC 
BTH_II0969 cbcX 136.6 NC NC NC 
BTH_II0970  37.7 NC NC NC 
BTH_II0971  8.8 NC NC NC 
BTH_II0994 souR 3.9 NC 4.7 NC 
BTH_II0995 sdaA-2 90.8 NC 32.3 NC 
BTH_II0996 soxB 130.6 NC 39.3 NC 
BTH_II0997 soxD 172.0 NC 102.3 NC 
BTH_II0998 soxA 122.7 NC 58.6 NC 
BTH_II0999 soxG 24.9 NC 11.7 NC 
BTH_II1000  7.6 -3.2 8.7 -3.5 
BTH_II1546  4.3 NC 3.7 NC 
BTH_II1853  5.4 NC NC NC 
BTH_II1854 cosX 7.1 NC NC NC 
BTH_II1855 betC 3.8 NC NC NC 
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BTH_II1856  11.5 NC NC NC 
BTH_II1857 purU2 8.4 NC NC NC 
BTH_II1858  6.5 NC NC NC 
BTH_II1859 betX 175.6 NC 38.6 NC 
BTH_II1860 gbcB 115.8 NC 28.9 NC 
BTH_II1861 gbcA 110.8 NC 23.7 NC 
BTH_II1862  218.7 NC 44.4 NC 
BTH_II1863  163.4 NC 97.2 NC 
BTH_II1864 dgcB 154.1 NC 28.9 NC 
BTH_II1865 dgcA 199.7 NC 23.4 NC 
BTH_II1866  223.9 NC 29.8 NC 
BTH_II1867  135.3 NC 47.4 NC 
BTH_II1868 glyA 162.9 NC 20.7 NC 
BTH_II1869 gbdR1 2.6 NC NC NC 
a Constraints on inclusion in table were +/- 2.3 fold change and p ≤ 0.005 based on the 
wild type. 
b Gene names are putative based on homology to P. aeruginosa.  
c NC, no change due to significance, lower fold change, or experimental deletion of the 
gene. 
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Table 2.S1 – Strains and plasmids. 
Designation Genotype or Description Reference or Source 
   Burkholderia 
thailandensis strains 
  MJ358 E264 wild type (23) 
AN3  ΔgbdR1 This study 
AN19 ΔgbdR2  This study 
AN16 ΔgbdR1 ΔgbdR2 This study 
AN126 ΔsouR This study 
AN202 ΔgbdR1 ΔsouR This study 
AN205 ΔgbdR2 ΔsouR This study 
AN207 ΔgbdR1 ΔgbdR2 ΔsouR This study 
AN136 attTn7 vector, Zeor This study 
AN153 attTn7 vector, Zeor This study 
AN128 attTn7 vector, Zeor This study 
AN150 attTn7 vector, Zeor This study 
AN158 ΔgbdR1 att::gbdR1 comp, Zeor This study 
AN173 ΔgbdR2 att::gbdR2 comp, Zeor This study 
AN162 ΔgbdR1 ΔgbdR2 att::gbdR1, Zeor This study 
AN164 ΔgbdR1 ΔgbdR2 att::gbdR2, Zeor This study 
AN151 att::souR comp, Zeor This study 
AN191 pAN27 This study 
AN192 ΔgbdR1 + pAN27 This study 
AN193 ΔgbdR2 + pAN27 This study 
AN194 ΔgbdR1 ΔgbdR2 + pAN27 This study 
AN192 ΔsouR + pAN27 This study 
AN226 pAN28 This study 
AN227 pAN29 This study 
AN228 pAN30 This study 
AN229 pAN31 This study 
   Escherichia coli strains 
  DH5α 
  T7 Express See manufacturer NEB 
AN133 pAN13 in T7 Express 
 AN134 pAN14 in T7 Express 
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AN188 pAN19 in T7 Express 
 
   Plasmids 
  pMQ132 Yeast recombineering vector, Gmr (38) 
pAN1 pMQ132 derivative, Tpr This study 
pAN7 
pAN1 derivative, lacZYA reporter 
plasmid, Tpr This study 
pAN27 pAN7-PglyA -408 This study 
pAN28 pAN7-PglyA -340 This study 
pAN29 pAN7-PglyA -251 This study 
pAN30 pAN7-PglyA -147 This study 
pAN31 pAN7-PglyA -85 This study 
pMAL-C2X 
N-terminal MBP affinity tagging, 
Ampr NEB 
pAN13 pMAL-C2X-gbdR1 This study 
pAN14 pMAL-C2X-gbdR2 This study 
pAN19 pMAL-C2X-souR This study 
pUC18-mini-TN7T-Zeo attTn7 integration vector, Zeor (26) 
pTNS2 carrying the attTn7 transposase, Ampr (59) 
pAN23 pUC18-mini-TN7T-Zeo-gbdR1 comp This study 
pAN10 pUC18mini-TN7T-Zeo-gbdR2 comp This study 
pAN22 pUC18-mini-TN7T-Zeo-souR comp This study 
   
   
   
 
Table 2.S2 – Primers used in study. 
Bt-gbdR1-
TpFLP-1F 
gcgccccggccgcatcaagatcagatccaaggaacgcttcGA
GCTCGAATTAGCTTCAAA 
gbdR1 (BTH_II1869) 
deletion 
Bt-gbdR1-
TpFLP-1R 
ggtgtgcgatttcgggggccggtttcgagttccggtttccGAGC
TCGAATTGGGGATCTT 
gbdR1 (BTH_II1869) 
deletion 
Bt-gbdR1-
2F 
CGTAATCGATCAGCATCGTG gbdR1 (BTH_II1869) 
deletion 
Bt-gbdR1-
2R 
GAAGCGTTCCTTGGATCTGA gbdR1 (BTH_II1869) 
deletion 
Bt-gbdR1-
3F 
GGAAACCGGAACTCGAAAC gbdR1 (BTH_II1869) 
deletion 
Bt-gbdR1-
3R 
ACGTCGAGACGCTGAGGAT gbdR1 (BTH_II1869) 
deletion 
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BtgbdR2 
proximal F 
AAG CCG TGC CGA TGT GGC TG gbdR2 (BTH_II0968) 
deletion 
BtgbdR2 
proximal R 
AAG ATC GAC CAG CGG TAA TG gbdR2 (BTH_II0968) 
deletion 
BtgbdR2 tp 
F 
REVISED 
ACTACGTCGCGCGCGCGGACCATTACCG
CTGGTCGATCTTgagctcgaattagcttcaaa 
gbdR2 (BTH_II0968) 
deletion 
BtgbdR2 tp 
R 
REVISED 
TACGCCTTGCTGAAATGGCACGGCGAGT
GAAAGCCGCAGAgagctcgaattggggatctt 
gbdR2 (BTH_II0968) 
deletion 
BtgbdR2 
post F 
REVISED 
TCTGCGGCTTTCACTCGCCG gbdR2 (BTH_II0968) 
deletion 
BtgbdR2 
post R 
REVISED 
CGCCGCCGCTCAGATAGTCG gbdR2 (BTH_II0968) 
deletion 
BtII0994pr
oxF 
CGGCAATCTACGATGAGGCT souR (BTH_II0994) 
deletion 
BtII0994pr
oxR 
CGATAGGGGGAAGAACACCG souR (BTH_II0994) 
deletion 
BtII0994po
stF 
GGTCAGCGTGAAGTTAGGCA souR (BTH_II0994) 
deletion 
BtII0994po
stR 
CCGATGTCGTCCTTCTCGTC souR (BTH_II0994) 
deletion 
BtII0994tp
F 
GCCGCCGGCCGCATCGGCGTCGGTGTTC
TTCCCCCTATCGgagctcgaattagcttcaaa 
souR (BTH_II0994) 
deletion 
BtII0994tp
R 
GCGCTTCGGGATCGTGCTGCTGCCTAACT
TCACGCTGACCgagctcgaattggggatctt 
souR (BTH_II0994) 
deletion 
gbdR1com
pFHindIII 
CCTAAGCTTGAGCGACATCCCGAGCACC
G 
gbdR1 complement 
gbdR1com
pRKpnI 
CTTGGTACCCGGGGGCCGGTTTCGAGTT
C 
gbdR1 complement 
KpnIgbdR2
compF 
CTT GGTACC CTGACGTTTTCCGCCTTCG gbdR2 complement 
EcoRIgbdR
2compR 
CTT GAATTC GGGATCGGTTCGTGGCTG gbdR2 complement 
KpnI 
II0994com
pF 
CTT GGTACC 
CCTTGCGTAACGATGCGTGGT 
souR complement (use 
MBP-SouR reverse 
primer) 
Tp 
pMQ132F 
TACGCCGTGGGTCGATGTTTGATGTTATG
GAGCAGCAACGgatcccctgattccctttgt 
Generation of pAN1 
Tp 
pMQ132R 
ACTCCGCGGCCGGGAAGCCGATCTCGGC
TTGAACGAATTGagcgcttttgaagctgatgt 
Generation of pAN1 
BtPFusion
YHRp1F 
CTACTGCCGCCAGGCAAATTCTGTTTTAT
CAGACCGCTTC GAATTC CTGCCCG 
Generation of pAN7 
step 1 
BtPFusion GCAGCTGGCACGACAGGTTTCCCGACTG Generation of pAN7 
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YHRp1R GAAAGCGGGCAG GAATTC GAAGCGG step 1 
BtPFusion
YHRp2F 
CTACTGCCGCCAGGCAAATTCTGTTTTAT
CAGACCGCTTC ccaagcttgcatgcctgcag 
Generation of pAN7 
step 2 
BtPFusion
YHRp2R 
GCAGCTGGCACGACAGGTTTCCCGACTG
GAAAGCGGGCAG 
gaattCGCAGCGTATCAGGC 
Generation of pAN7 
step 2 
glyAtogbd
R1interF 
CCTGCATGCAAGGCGTCTCGTCACTGGA
T 
Generation of pAN27 
glyAtogbd
R1interR 
CTTGCATGCGGGGAAGCGTTCCTTGGAT
CT 
Generation of pAN27 
SphI 
P.glyA1Lac
Z1 
CTT GCATGC 
CGCAACTAGCGTGCCATACG 
Generation of pAN28, 
use with 
glyAtogbdR1interR 
SphI 
P.glyA1Lac
Z2 
CTT GCATGC CTGCGCAGCGCGAGTG Generation of pAN29, 
use with 
glyAtogbdR1interR 
SphI 
P.glyA1Lac
Z3 
CTT GCATGC 
GAAAGCGTCTGAATTCATCAATCGG 
Generation of pAN30, 
use with 
glyAtogbdR1interR 
SphI 
P.glyA1Lac
Z4 
CTT GCATGC CCGCTGCGGCGGAAC Generation of pAN31, 
use with 
glyAtogbdR1interR 
gbdR1EMS
A2F 
GGGGTTGGCGTTCGACATAA EMSA Probe 2 
gbdR1EMS
A2R 
CGGAAAAGGGAAAGAAAGCGT EMSA Probe 2 
BIOgbdR1
EMSA2F 
BIO-GGGGTTGGCGTTCGACATAA EMSA Probe 2 
gbdR1EMS
A3R 
GCTAAACCCTAGATCGGCGG EMSA Probe 1 
gbdR2EMS
A1F 
CAGCGTATGCAGGAACGGG EMSA Probe 1 
BIOgbdR1
EMSA3F 
BIO-TGTCGTTCGGATTTTTAGCCG EMSA Probe 1 
SarOxiEM
SA1F 
CGGTCATGTCTGCAAAATCGT EMSA Probe 3 
SarOxiEM
SA1R 
GCCGATAGAACAAAAACGGCA EMSA Probe 3 
BioSarOxi
EMSA1F 
BIO-CGGTCATGTCTGCAAAATCGT EMSA Probe 3 
pMALC2X
gbdR1F 
CCTGGATCCTCGCCCGACCGCACCGCG MBP-GbdR1 
RSFgbdR1
R 
CTT AAG CTT TCA GCG CGC CGA CAC 
GCG 
MBP-GbdR1 
MALgbdR
2F 
CCG GGATCC GTG ACG TCC GCC GCC 
GCT 
MBP-GbdR2 
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6hisgbdR2
R 
CTTAAGCTTTCAGCGCGCCGACACGCG MBP-GbdR2 
BamHI 
II0994 
pMAL F 
CCG GGATCC 
GTGCGTTTCGGCGATGGTTC 
MBP-SouR 
HindIII 
II0994 
pMAL R 
CCT AAGCTT TCAGCGAGCGCCCCTC MBP-SouR and souR 
complementation 
BtRplURT
F 
CAGTACAAGGTTGCCGTTGG rplU qRT-PCR set 
BtRplURT
R 
CCGTGCTTTTGGTAGTGCTTC rplU qRT-PCR set 
II1861RTF GCAGCAGATACGGCTCCATC gbcA qRT-PCR set 
II1861RTR GCAACGAGGAAAAAGGGTCG gbcA qRT-PCR set 
II0996RTF CTCGAACTACCTGTGGGACG soxB qRT-PCR set 
II0966RTR AAGTTGATCGTCGGCTCGAT soxB qRT-PCR set 
II0994RTF CGTTGCCTTTCTGCATCTCG souR qRT-PCR set 
II0994RTR TGCGTGAGCTGGTTCCATTA souR qRT-PCR set 
BtgbdR1 
RT F 
AGTGCTCAGGATGGCAAACT gbdR1 qRT-PCR set 
BtgbdR1 
RT R 
CAGATTTTCCCAATGGATCG gbdR1 qRT-PCR set 
gbdR2 set3 
RTF 
CAGGTGTCCGAGCAGTTCAT gbdR2 qRT-PCR set 
gbdR2 set3 
RTR 
CGGCGACACGTTCAGATAGA gbdR2 qRT-PCR set 
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CHAPTER 3:  
 
EXPLORATION OF GATRS IN B. THAILANDENSIS 
 
3.1 Abstract 
 Glutamine amidotransferase1 (GATase1)-containing AraC-family transcriptional 
regulators (GATRs) represent a widely disseminated class of regulator about which little 
is known. Given the particularly high presence of GATRs in β-proteobacteria, we choose 
to use the genetically tractable Burkholderia thailandensis as a model organism to 
increase our knowledge of these regulators. Phylogenetic comparisons of GATRs 
between Burkholderia species were made to determine how representative B. 
thailandensis is of other Burkholderiales. A small library of molecules was assembled 
based on functional predictions and potential orthologs of unknown GATRs. GATR 
deletions strains were screened against the library for growth on these compounds as 
either a carbon or nitrogen source, resulting in the identification of two additional GATRs 
in B. thailandensis.   
  To assess the functions of the remaining unknown GATRs, we developed a 
strategy to generate constitutive mutants by perturbing the predicted dimerization domain 
based on known constitutive mutations and a known crystal structure. We constructed a 
constitutively active mutant of a known GATR, GbdR, in P. aeruginosa, which led to the 
induction of genes involved in choline and glycine betaine transport and catabolism. 
When this strategy was applied to a GATR of unknown function in B. thailandensis, 
I0685, we found that I0685 acts as a repressor of an operon encoding glutathione-
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dependent formaldehyde dehydrogenase. This function was additionally confirmed by 
growth assays in the presence of formaldehyde.  
 
3.2 Introduction 
  Glutamine amidotransferase1 (GATase1)-containing AraC-family transcriptional 
regulators (GATRs) are a broadly occurring, yet poorly understood subfamily of AraC-
family transcriptional regulators (ATRs). Currently there are few well-characterized 
members of the GATR subfamily. In order to better understand this subfamily of 
regulators, we sought to identify and characterize additional GATRs.  
  The ATR family is a prevalent and widespread family of regulators in bacteria (1-
3). ATRs are typically around 300 to 350 amino acids long. Structurally, ATRs may be 
divided into two domains separated by a short linker region (Figures 1.1). The C-terminal 
domain contains two helix-turn-helix motifs that are responsible for promoter 
recognition. The N-terminal domain is responsible for ligand binding and dimerization, 
and typically includes an unstructured N-terminal arm. ATRs typically function as dimers 
and bind two degenerate direct repeat half sites proximal to the transcriptional start site 
where they function as activators. The mechanism of activation for ATRs involves the 
perturbation of dimerization between monomers caused by ligand binding.  
  The namesake member of the family, AraC, activates transcription by the ‘light-
switch’ mechanism whereupon transcription is repressed by DNA looping due to a 
preference for a distal upstream half site (Figures 1.2) (4). Binding of arabinose to the 
AraC dimer results in a shift in preference for binding sites to the two half sites proximal 
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to the transcriptional start site, thereby activating expression of the target operon. This 
shift in orientation of the dimer is caused by interaction between the N-terminal arm, and 
the ligand binding domain when arabinose is bound (5). Alternatively, dimers of other 
ATRs such as RegA remain in solution until their ligand is bound, which then causes the 
nature of the dimer to change and bind to its target promoter and activate transcription 
(Figures 1.3) (3, 6).  
  GATRs are distinguishable from other ATRs based on the homology of the N-
terminal dimerization and ligand recognition domain to the GATase1 family of enzymes 
(7, 8). GATases catalyze the transfer of amide groups to various substrates (9). GATase1 
domain-containing enzymes include anthranilate synthases, CTP synthases, GMP 
synthetases, and 2-amino-2-desoxyisochorismate synthases among many more, which are 
responsible for producing a wide range of both primary and secondary metabolites (10-
12). GATase1 domains may be fused to a synthase domain or translated as an 
independent peptide, which forms a heterodimer with a synthase domain (9). GATase1 
domain-containing proteins often function as dimers or sometimes higher order 
oligomers. In some cases, higher order oligomerization leads to the production of 
proteinaceous filaments, such as in CTP synthetase, where filament formation negatively 
regulates enzyme activity in the presence of excess product (13). Many GATRs also 
share a conserved cysteine, the remnant of a cysteine/glutamate/histidine catalytic triad 
stemming from the homology to GATase1 enzymes. 
  GATRs are found in both Gram-positive and Gram-negative bacteria, with a 
notably higher presence in proteobacteria based on currently available sequence data 
(14). While many GATR-possessing bacteria encode only one or two homologs, other 
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genomes may contain more. For example, Pseudomonas aeruginosa encodes seven (15) 
and Burkholderia cenocepacia encodes fifteen (16). To investigate the diversity and 
functionality of GATRs, Burkholderia thailandensis was chosen as a model organism 
based on the availability of genetic tools and its genetic tractability (17-20). 
  The genome of B. thailandensis contains thirteen bioinformatically predicted 
GATRs including putative orthologs of all GATRs present in the closely related select 
agents Burkholderia pseudomallei and Burkholderia mallei, the etiological agents of 
melioidosis and glanders (21, 22). B. thailandensis also contains putative orthologs of 
GATRs found elsewhere in the Burkholderia genus, making the model a respectable 
survey of the GATR family found here and in more distally related bacteria (Figures 3.1, 
3.2, and Table 3.4).  
    Previously identified GATRs in P. aeruginosa, GbdR and ArgR, have been 
shown to function as transcriptional activators for genes involved in the transport and 
catabolism of glycine betaine (GB) and arginine respectively (23-26). To better 
understand the function of B. thailandensis GATRs, and what compounds GATRs might 
enable the bacterium to utilize, we generated deletion strains of each GATR. 
Synthesizing the functional predictions for adjacent and co-occurring genes with our 
knowledge of known GATRs, deletion strains were screened against a collection of 
potential metabolites as sole carbon and nitrogen sources. Using these screen we 
identified orthologs of the GATRs ArgR and CdhR. 
  In order to identify the regulons of additional unknown GATRs, we designed an 
approach based on perturbation of the dimerization of GATRs to achieve differential 
expression of their target operons independent of ligand by combining information about 
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known constitutive mutants in characterized GATRs with predicted protein structures. 
Utilizing this method, we found that the unknown GATR, I0685, is responsible for 
regulating glutathione-dependent formaldehyde detoxification. Interestingly, this 
regulation is due to repression by I0685 revealing that GATRs may act as repressors, 
contrary to previous data that suggested GATRs function solely as activators (26-29). 
  The regulation of formaldehyde metabolism is important for bacteria, as 
formaldehyde at high concentrations may damage and interfere with other biological 
processes (30). Simultaneously, lower amounts of formaldehyde may be useful as singly 
carbon building blocks for more complex molecules (31). Choline catabolism in B. 
thailandensis produces three molecules of formaldehyde per molecule of choline, and 
three different GATRs are already known to impact the regulation of this pathway (32). 
Formaldehyde can also be generated in bacteria as a result of methylglyoxal degradation, 
which can be generated by glyceraldehyde oxidation and the degradation of 
glyceraldehyde-3-phosphate or dihydroxyacetone-phosphate (33). The finding of an 
additional GATR that impacts formaldehyde catabolism is an interesting link to the 
GATR-regulated catabolism of choline.  
  
3.3 Results 
3.3.1 Phylogenetic comparison of GATRs in Burkholderia. 
 Alignment of the full length sequences of Burkholderia species GATRs resulted 
in a general grouping of the GATRs into three groups (Figure 3.1). The first group 
consists of orthologs of GbdR1, GbdR2, SouR, CdhR, and ArgR, all except ArgR 
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regulate different metabolic pathways related to GB catabolism. The second group 
includes I1350, I0685, II1912, II0513, and several B. cenocepacia GATRs that do not 
have apparent orthologs in the other Burkholderiales. The third group includes II2197, 
II0282, and II1760. All the members of this clade are bioinformatically labeled as FtrA or 
FtrA-like, a GATR accociated with accessory nitrogen metabolism present in 
Caulobacter crescentus (34). However, upon comparison of the clustering with FtrA 
from Yersinia enterocolitica and C. crescentus, and the conserved synteny of a putative 
rhodanese divergently transcribed from it, II1760 is likely the genuine ortholog of FtrA as 
identified from E. coli (Figures 3.1, 3.2). Because the DNA binding domain might drive 
alignments due to similarities in HTH motifs subjected to possible selective pressure 
based on similarities between target binding sites, we also generated a phylogenetic tree 
based on alignment of only the GATase1-like domain (Figure 3.2). The similar results 
suggest that the alignments produced were not strongly influenced by the C-terminal 
domains. The GATR I0059 does not fit into any one of the clade in either alignment.  
  To further investigate the groupings of putative orthologs derived from the 
alignments, gene synteny and co-occurrence of the nearby genes using the STRING 
database and the Burkholderia Genome Database were utilized (16, 35), generating Table 
3.4. These comparisons suggest that the phylogenetic clustering is accurate. However, the 
association of BCAS0761 with a particular group based on Table 3.4 was not clear. The 
phylogenetic alignments group BCAS0761 with I0685 and it co-occurs with orthologs of 
genes encoding glutathione-dependent formaldehyde dehydrogenase and an associated 
esterase (I0686 and I0687). Orthologs of I0686 and I0687 in P. aeruginosa are regulated 
by GfnR, a LysR-family regulator. GfnR is not present in B. cenocepacia suggesting an 
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alternative regulator such as an ortholog of I0685 may be required for regulation of these 
genes (28).  
  B. mallei does not contain an ortholog for SouR, despite possessing orthologs for 
GbdR1, GbdR2, and CdhR.  
 
3.3.2 GATR functionality by screening carbon and nitrogen utilization.  
  Our knowledge of the inducing ligands for GbdR and ArgR in P. aeruginosa (25, 
36) and bioinformatic predictions for genes either adjacent or co-occurring with GATRs 
(Figure 1.7), allowed for the assembly of a collection of compounds to screen as a sole 
carbon or nitrogen sources to determine if the GATR deletions displayed phenotypes 
under any of these conditions. Deletion strains were generated for every GATR in B. 
thailandensis, except for II1912, which differs in length and orientation between differing 
strains of B. thailandensis, and may not conserved or functional in B. thailandensis E264.  
  ΔgbdR1, ΔgbdR2, and ΔsouR strains exhibited growth defects on choline, glycine 
betaine, dimethylglycine, and sarcosine as sole carbon sources (Figure 3.3). ΔgbdR1 and 
ΔgbdR2 grew on sarcosine as a sole nitrogen source. However, the ΔsouR strain 
demonstrated no growth on sarcosine (Figure 3.4). These results support our previous 
findings (32), thus serving as effective controls for the screen. Different strains appeared 
to exhibit large differences in growth rates on a large set of compounds, which may be 
partially explained by differences associated with the biofilm phenotype discussed in 
Appendix 1.  
  ΔgbdR1, ΔgbdR2, and ΔsouR strains were unable to utilize choline-O-sulfate as 
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either a sole carbon or nitrogen source compared to wild type (Figures 3.3 and 3.4). 
Choline-O-sulfate is utilized in some plants, fungi, and bacteria as a compatible solute or 
as management for high levels of sulfate (37-39).  
  Two other deletion strains exhibited growth defects in the screen. ΔII1850 was 
unable to grow on carnitine as either a sole carbon or nitrogen source (Figures 3.3 and 
3.4). This suggests that II1850 is likely an ortholog for CdhR, a GATR in P. aeruginosa 
shown to regulate genes for carnitine transport and catabolism (40). The second strain, 
ΔI1774, was defective in growth on arginine as a sole carbon source (Figure 3.3) and 
appeared to utilize arginine as a sole nitrogen source at a diminished rate compared to 
wild type and other strains (Figure 3.4). This result suggested that I1774 may be an 
ortholog for ArgR, a GATR in P. aeruginosa responsible for regulating genes involved in 
arginine synthesis and catabolism (26).  
 
3.3.3 Deletion of II1850 results in a catabolic defect on carnitine as a sole carbon 
source. 
  The synteny of genes adjacent to cdhR in P. aeruginosa and II1850 are identical 
and encode similar proteins, suggesting II1850 is a cdhR ortholog (Figure 3.5A). The 
cdhA, cdhB, and cdhC genes encode proteins directly responsible for the catabolic 
degradation of carnitine into glycine betaine (40). caiX, a gene encoding a periplasmic 
binding protein, is responsible for the transport of carnitine from the periplasmic space 
through interaction with CbcWV, an ATP-binding cassette transporter (41). Finally, hocS 
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encodes hydrolase responsible for the degradation of short-chain O-acetyl carnitines that 
also feeds into this catabolic pathway (42).  
  Growth of ΔII1850 on carnitine as a sole carbon source on MOPS minimal media 
plates confirms the catabolic defect previously observed in catabolic screens (Figure 
3.5B). This defect was complemented by addition of II1850 back onto the chromosome at 
the attTn7 site, under the control of its native promoter (Figure 3.5B, right panel). The 
wild type, deletion, and complement strains are all capable of growing on pyruvate under 
these growth conditions (Figure 3.5B, left panel).  
   
3.3.4 Deletion of I1774 results in a catabolic defect on arginine as a carbon source. 
 Comparison of the genomic context of I1774 in B. thailandensis with the genomic 
context of argR in P. aeruginosa reveals an adjacent operon containing predicted 
arginine succinyltransferase pathway (AST) genes (Figure 3.6A). These GATRs are both 
located at the end of a transport operon. This operon is described as being responsible for 
the transport of arginine and ornithine under the regulatory control of ArgR (25). The 
arrangement of these operons differs between these species, with the B. thailandensis 
operon containing only putative orthologs to aotQ (I1771), aotM (I1772), and aotP 
(I1773). A potential ortholog for aotJ (I1783), a periplasmic binding protein that 
primarily contributes to the uptake of arginine (25), is located proximally to AST genes. 
Additionally, an ortholog for autO (II2133) exists, but it is not strictly required for 
arginine catabolism (25).  
100 
 
  Deletion of I1774 results in a defect in growth on arginine as a sole carbon source 
(Figure 3.6B, right panel). This defect is complemented by addition of the I1771-4 
operon at the attTn7 site under the control of its native promoter. All strains were able to 
grow on pyruvate as a sole carbon source under these conditions (Figure 3.6B, left panel). 
Efforts to complement the phenotype using just I1774 and the immediate 200 bp 
upstream from it were unsuccessful, likely because I1774 is part of an operon and the 
native promoter required for expression is located upstream from I1771 (data not shown). 
 
3.3.5 GbdR E36G constitutively upregulates transcription of members of the GbdR 
regulon.  
  Discovering the function of the remaining unknown GATRs presented a hurdle as 
neither their ligand nor the genes they regulate are known. The construction of 
constitutively active transcriptional regulators might be used to identify genes that are 
upregulated in a ligand independent manner. In order to determine whether constitutively 
active GATRs can be constructed based on examples of constitutive mutation in SouR 
from P. aeruginosa and the crystal structure 3GRA from P. putida (Figure 3.7), we 
focused on GbdR in P. aeruginosa as a model since its regulon and function is 
understood (23). A GbdR E36G strain was designed based on the predicted structural 
homology to the D48G allele constitutive mutant of SouR in P. aeruginosa PA14 (Table 
3.5). This mutant allele was capable of rescuing the catabolic phenotype of ΔgbdR on 
choline as a sole carbon source (Figure 3.8), demonstrating that the protein is functional. 
When grown in the absence of choline, the inducing ligand, microarray analysis revealed 
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that transcripts in the GbdR regulon were upregulated (Table 3.6). These include genes 
responsible for the transport of choline and its metabolites such as cbcW and betX, as well 
as genes encoding enzymes that catabolize GB into glycine such as gbcA, soxA, soxB, 
and glyA among others. This result suggests successful construction of a constitutively 
active, ligand-independent version of GbdR. Similar mutations and analyses can be used 
to uncover the regulons of other GATRs. 
 
3.3.6 I0685 regulates expression of a formaldehyde dehydrogenase.  
  Similarly to our approach with GbdR, we constructed a ligand independent, 
constitutive I0685 by incorporating an N32G mutation based on comparison to 
constitutive mutations in SouR of P. aeruginosa and the crystal structure of 3GRA in P. 
putida (Table 3.5). I0685 is divergently transcribed from a highly conserved operon that 
includes a glutathione-dependent formaldehyde dehydrogenase and an associated 
esterase. Surprisingly, when the transcriptome of the N32G expressing strain was 
compared to the deletion strain, the adjacent dehydrogenase and esterase genes were 
significantly downregulated in the presence of the predicted “constitutive” mutant (Table 
3.7). This was opposite of the result we expected to observe based on our knowledge that 
other GATRs function as activators (24, 26).  The downregulation is dependent on the 
presence of the N32G mutant, and not simply due to accidental disruption of the 
promoter during deletion of I0685. It is possible that the mutation has resulted in a 
conformational change that causes insensitivity to de-repressing ligand that might 
normally be present. 
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  In order to further assess the potential impact on formaldehyde detoxification, 
I0685 deletions and complement strains were constructed in a ΔII1870 (orthologs 
commonly named fdhA) background in order to separate the impact of the glutathione-
dependent formaldehyde dehydrogenase from redundant detoxification by the 
glutathione-independent formaldehyde dehydrogenase. Previously, the multiple systems 
present in Burkholderia have been shown to successfully compensate for each other (43). 
Growth in the presence of formaldehyde revealed that the I0685 deletion had a slight 
growth advantage compared to the wild type. Complementation of I0685 back onto the 
chromosome was slightly deleterious, and complementation with the N32G mutant 
greatly inhibited growth in the presence of formaldehyde (Figure 3.9). This suggested 
that the I0685 may function to repress the expression of I0686 and I0687.  
 
3.4 Discussion 
3.4.1 Building constitutive regulators. 
  The construction of constitutively active transcriptional regulators is a useful tool 
both for uncovering details of mechanism and, as we have explored here, revealing target 
genes. Constitutive mutants in AraC have been previously published, with the majority 
being found to be localized in the N-terminal arm (44). Other constitutive mutations were 
found to occur in the dimerization domain itself and some in the DNA binding domain 
(45). Contrary to the experience of other groups, all constitutive mutations we have 
identified experimentally occur in the predicted dimerization face of the N-terminal 
domain (Figure 3.7). Although GATRs also appear to possess an unstructured N-terminal 
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arm, it is not well-conserved and it is unclear if the N-terminal arm plays an important 
mechanistic role in GATR function. However, GATase functionality is heavily dependent 
on ligand induced conformational changes, which are necessary for proper formation of 
ammonia channels to supply associated synthase domains (8). Because dimerization or 
higher oligomerization of GATase-containing enzymes is critical to proper formation of 
ammonia channels and orientation of active sites for functionality, it stands to reason that 
altering the ability to undergo conformational changes through mutations in the 
dimerization domain might greatly affect the functionality of the protein. Indeed, 
constitutive GATases have been constructed through mutation of residues critical for 
proper active conformation (46).  It is possible that the homology of GATRs to GATase1 
enzymes have contributed a mechanism for conformational change allowing GATRs to 
function through a conformational change-based mechanism similar to the mechanisms 
of other ATRs such as AraC and RegA.  
  In order to test our ability to generate constitutive GATRs, we utilized GbdR from 
P. aeruginosa as a model. GbdR is responsible for regulation of enzymes in the GB 
catabolic pathway, various transporters, and the extracellular phospholipase PlcH (23, 24, 
27). This pathway converts choline into the ubiquitous osmoprotectant GB and can 
further catabolize it through a series of demethylation steps ultimately into glycine. B. 
thailandensis also shares this catabolic pathway, although the gene organization and 
regulation scheme differs from P. aeruginosa and includes two GbdR orthologs instead 
of just one (32). GbdR is thought to bind DNA as a dimer due not only to similarities to 
ATRs, but more specifically to ArgR which has been shown to dimerize and share similar 
structure of the orientation of the direct repeat binding sites of within target promoters 
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(23, 25, 47). Using the combined information from the crystal structure of the N-terminal 
domain of 3GRA from P. putida and the constitutive mutants of SouR from P. 
aeruginosa, we were able to successfully generate a constitutive GbdR that activates 
transcription of target genes by altering a residue in the predicted dimerization domain. 
The alteration to the dimerization domain may alter the conformational preference of the 
dimer, resulting in a bias toward the activating conformation even in the absence of 
ligand. Currently it is unclear whether the change in conformation of this constitutively 
activating GbdR is altering an interaction with the RNA polymerase holoenzyme or 
changing the way in which GbdR acts with its DNA binding half sites, as in the case for 
AraC.  
 
3.4.2 Identification of a GATR acting as a repressor of formaldehyde detoxification. 
  Formaldehyde is a biologically significant molecule because it can be a useful one 
carbon building block, or a highly reactive molecule damaging proteins and DNA. 
Accordingly, the metabolism of formaldehyde must be tightly controlled (33). 
Consequently, bacteria utilize several pathways for formaldehyde detoxification. B. 
thailandensis is predicted to contain two formaldehyde detoxification pathways: a 
glutathione-independent formaldehyde dehydrogenase and a glutathione-dependent 
formaldehyde dehydrogenase. Other Burkholderiales have been shown to contain other, 
alternative pathways for formaldehyde detoxification. Burkholderia cepecia TM1 
possesses genes encoding a ribulose monophosphate-dependent pathway shown to be 
important for the detoxification of formaldehyde generated by the degradation of lignin 
from plant matter (48, 49). Closely related and previously classified as a Burkholderia, 
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Paraburkholderia fungorum LB400 utilizes the pterin-dependent formaldehyde 
detoxification pathway which is dependent on either the pterin-containing 
tetrahydrofolate or tetrahydromethanopterin. This pathway is widespread amongst 
bacteria due to utilization in the one carbon transfer needed for the synthesis of purines 
and amino acids (33, 43).  
  The glutathione-independent formaldehyde dehydrogenase, II1870, is adjacent to 
gene required for GB catabolism. Transcription of II1870 may be under the regulatory 
control of the GbdR orthologs GbdR1 and GbdR2 in addition to a conserved raffinose 
repressor in the same operon (32). This reaction relies on NAD+ and results in the 
generation of formate (50). The close association between II1870 and GB catabolism is 
likely due to the three molecules of formaldehyde produced for every molecule of GB 
that is catabolized to pyruvate (36).  
  The glutathione-dependent pathway utilizes glutathione to react with 
formaldehyde resulting in S-hydroxymethylgluathione, which is then converted to S-
formylglutathione by the formaldehyde dehydrogenase (I0686 in B. thailandensis) (51, 
52). An associated esterase (I0687 in B. thailandensis) then converts this product into 
formate and regenerates glutathione (53). While the glutathione-dependent formaldehyde 
dehydrogenase and esterase are regulated by the LysR-family transcriptional regulator 
GfnR in P. aeruginosa and many other bacteria, B. thailandensis has no ortholog for 
GfnR. Instead an unknown GATR, I0685, is divergently transcribed from the operon 
containing these genes (28). Operons divergently transcribed from their regulator is a 
common gene arrangement (54). 
  We applied our strategy for constructing constitutive GATRs to I0685. We 
106 
 
expected a ligand-independent upregulation of the glutathione-dependent formaldehyde 
dehydrogenase and esterase genes. Surprisingly, the deletion strain expressing I0685 
N32G significantly downregulated expression of these genes when compared to an I0685 
deletion strain carrying the empty vector (Table 3.7). The change in expression of these 
genes stimulated the investigation of the effects of formaldehyde on the growth of 
various strains. Strains producing wild type, or particularly I0685 N32G, have reduced 
tolerance of formaldehyde compared to the deletion itself, likely due to direct repression 
of I0686 and I0687.  
  The I0685 regulatory mechanism is novel in multiple ways. First, characterized 
ATRs are typically activators (3, 55) and this marks the first incidence of any GATR 
acting specifically as a repressor. Second, GATRs have been associated with smaller 
amine-containing compounds such as arginine, carnitine, GB, and sarcosine. However, 
I0685-7 are not transcribed in a GB- or GbdR- dependent manner, and the upregulation 
of I0686-7 has been observed in connection with the catabolism of GB, which produced 
formaldehyde (32). It is quite possible that formaldehyde itself is the ligand to which 
I0685 is responding, which suggests not all GATRs respond to amine-containing 
compounds as we had initially suspected.  
 
3.4.3 II1850 regulates carnitine catabolism. 
  Carnitine is an abundant metabolite in many environments (56) and found in 
particularly high levels in muscle tissue (57). Carnitine is also found in plants, but in far 
lower concentration than in animals (58). Animals use carnitine to shuttle fatty acids by 
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using O-acylcarnitine shuttles, with the acylcarnitines being generated by the liver (59-
61). Interest in carnitine has been piqued recently because gut microbiota have been 
shown to metabolize dietary carnitine into trimethylamine that is then converted by the 
host into trimethylamine-N-oxide, which has been linked to atherosclerosis (62, 63). In 
addition to utilizing carnitine as a carbon and/or nitrogen source, examples of both Gram-
negative and -positive bacteria have been shown to use carnitine as an osmoprotectant 
directly, or by catabolism into GB (40, 64-67).  
  II1850 is clearly an ortholog of CdhR in B. thailandensis given the similarity in 
gene synteny and phenotype of the deletion strains when compared to P. aeruginosa 
(Figure 3.5). The presence of a carnitine catabolic pathway provides another route to 
acquire the osmolyte GB. In addition, the pathway provides yet another opportunity for 
taking advantage of available nutrients that may be present when the bacterium is in 
association with decaying plant or animal matter in the environment.  
 
3.4.4 I1774 regulates arginine catabolism. 
  The metabolism of arginine in Gram-negative bacteria is well characterized and 
typically regulated in large part by one of two unrelated regulators named ArgR. ArgR in 
E. coli is a hexameric repressor regulating genes involved in arginine transport and 
metabolism (68, 69). In bacteria lacking the hexameric repressor, a GATR alternative 
(also called ArgR) is often found. The GATR ArgR has been shown to regulate genes 
involved in arginine biosynthesis, as well as genes in the AST pathway in P. aeruginosa 
(26). This pathway is one of four pathways responsible for arginine utilization and is 
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considered the primary pathway responsible for the aerobic catabolism of arginine (70). 
  ArgR in P. aeruginosa regulates ldcA, a gene responsible for lysine catabolism, in 
an arginine dependent manner. It is hypothesized that the lack of lysine-responsive 
control of these genes accounts for poor utilization of lysine as a sole carbon source, 
despite being able to utilize lysine when arginine is present (71). A similar regulation 
scheme may be present in B. thailandensis, either due to regulation of lysine 
decarboxylases or the specific regulation and specificity of the assorted substrate 
periplasmic binding proteins. The presence of such a regulation scheme might explain the 
lack of growth of B. thailandensis strains on lysine as a sole carbon source in our screen 
(Figure 3.3).  
  Based on the catabolic phenotype and high degree of homology between parts of 
the arginine transport and catabolic pathway components, I1774 is an ortholog of ArgR. 
Similarities between components of the P. aeruginosa AST pathway and observed 
phenotypes in B. thailandensis suggest a similar approach to regulation in both 
organisms.  
 
3.4.5 II1760, a potential regulator of cyanide detoxification.  
 Many Proteobacteria possess a single GATR that has been bioinformatically 
classified as FtrA, while B. thailandensis contains three GATRs that are currently 
annotated as being FtrA-like: II0282, II1760, and II2197. In our phylogenetic analysis of 
the GATRs (Figure 3.11A), we included typical examples of FtrA from E. coli, C. 
crescentus, and Y. enterocolitica. The resulting phylogenetic trees definitively clustered 
these GATRs with II1760 and putative homologs from other Burkholderia. The synteny 
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of the divergently transcribed gene, II1761, versus its putative homologs is conserved in 
all of these examples (Figure 3.11B). This suggests that this adjacent gene is a likely 
regulatory target for II1760.  
  II1761 is predicted to encode rhodanese, an enzyme that detoxifies cyanide by 
converting it to thiocyanate (Figure 3.11C) (72). The toxicity of cyanide is often due to 
inhibition of cytochrome c or other electron receptors, consequently impairing aerobic 
respiration (73). Rhodanese-like proteins are widely distributed among eukaryotes, 
prokaryotes, and archaea, and may also contribute to sulfur and selenium metabolism in 
addition to their role in cyanide detoxification (74).  Many bacteria, specifically those 
with rhodanese, are of interest as potential bioremediation agents (75, 76). B. cepacia has 
been previously shown to degrade a wide range of cyanide containing compounds (77). 
Bacteria and fungi often produce cyanide containing compounds to facilitate competition 
or avoid predation (78). An antagonistic relationship between P. aeruginosa and B. 
cenocepacia has also been described in the cystic fibrosis lung environment wherein 
cyanide containing compounds produced by P. aeruginosa inhibit the growth of a 
particular strain of B. cenocepacia (79).  
  This raises the possibility of a GATR responsible for cyanide detoxification and 
that potentially uses cyanide as a ligand. More direct evidence of regulation of rhodanese 
by II1760 in B. thailandensis is still needed, and the function of this putative rhodanese 
remains to be ascertained. It is likely that this information will reflect the function of 
FtrA, perhaps the most pervasive GATR in proteobacteria, and its relationship to 
rhodanese in other species. 
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3.4.6 Significance of choline-O-sulfate. 
  Some plants rely on osmoprotectant other than glycine betaine. In particular the 
Plumbaginaceae, a salt-tolerant group of plants, have evolved to accumulate choline-O-
sulfate to high levels in contrast to osmoprotectants such as glycine betaine (80). Choline-
O-sulfate has also been speculated to be involved in bacteria-plant communication (81). 
B. thailandensis possesses genes predicted to transport and catabolize choline-O-sulfate, 
which were found to be induced in the presence of choline in our previous studies (32), 
and could be expected to feed into the downstream choline and glycine betaine catabolic 
pathways. Because the precise environmental niche of many Burkholderia species is not 
yet fully appreciated, perhaps this metabolic capacity is suggestive of co-occurrence with 
organisms commonly capable of producing and exuding choline-O-sulfate. 
 
3.4.7 The absence of SouR in B. mallei. 
  Although it is tempting to speculate that one of the remaining GATRs may be 
responsible for regulation of the downstream portion of GB catabolism, further 
examination reveals that there are no putative orthologs of tetrameric sarcosine oxidase 
by BLAST (32). Sarcosine may also be catabolized by monomeric sarcosine oxidase (82, 
83), but a putative ortholog is not obvious. It is possible that B. mallei either lacks the 
ability to utilize GB metabolites as carbon or nitrogen sources or that it possesses an 
alternative pathway not yet appreciated. 
 
3.5 Methods 
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3.5.1 Alignment of GATRs and phylogenetic tree construction.  
  The full length sequence of all GATRs from B. thailandensis E264, B. 
pseudomallei K96243, B. mallei ATCC 23344, B. cenocepacia J2315, and several 
GATRs bioinformatically identified as orthologs of FtrA, in addition to AraC and PyrG 
from Escherichia coli, were aligned using the MUSCLE algorithm (84). In addition, the 
predicted GATase1-like domains for these GATRs and PyrG were also aligned and 
compared in order to eliminate similarity driven by HTH domains that bind similar DNA 
sequences. Maximum likelihood phylogenetic trees were generated using the MEGA6 
software package (85). Each phylogenetic tree was bootstrapped using five hundred 
bootstrap repetitions.  
 
3.5.2 Culture conditions for strains.   
  B. thailandensis, P. aeruginosa, and E. coli strains were typically plated on 
Lennox broth (LB) (10 g/L tryptone, 5 g/L yeast extract, 5 g/L NaCl, 1.5% agar) agar and 
grown at 37oC prior to generating overnights for experiments. Modified MOPS minimal 
media (86, 87) with and without NH4+ was used for growth on particular carbon or 
nitrogen sources, as well as inductions.  
 
3.5.3 Construction of deletion strains.   
Deletion strains in B. thailandensis were generated by inducing natural competency in 
combination with the introduction of splice overlap extension PCR products as described 
in Thongdee et al. using primers in (Table 3.3) (17). Trimethoprim resistance markers in 
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the resulting insertion-deletion mutants were removed utilizing pFLPe4 as described by 
Choi et al. (18).  
 
3.5.4 Carbon and nitrogen utilization screens.  
  A custom selection of compounds was derived from bioinformatics, functional 
predictions based on gene synteny, and co-occurrence of genes associated with unknown 
GATRs using the STRING database (35). Compounds for the carbon-source screen 
included pyruvate as a positive control, arginine, asparagine, β-alanine, N,N-dimethyl-β-
alanine, 4-aminobenzoic acid (PABA), glutamate, glutamine, glycine, histidine, proline, 
hydroxyproline, serine, O-acetyl L-serine, ornithine, lysine, threonine, taurine, histamine, 
ethanolamine, agmatine, canavanine, citrulline, ecotine, theanine, xanthine, urea, uric 
acid, trigonelline, ɣ-amino butyric acid (GABA), ɣ-butyrobetaine (GBB), guanidine, 
aminoethylethanolamine (AEEA), carnitine, choline-O-sulfate, choline, glycine betaine 
(GB), dimethylglycine (DMG), sarcosine, cadaverine, spermidine, putricine, N-acetyl-D-
glucose, N-acetyl-D-galactose, UDP-glucose, creatine, and creatinine. The nitrogen-
source screen included arginine, asparagine, β-alanine, N,N-dimethyl-β-alanine, cysteine, 
glutamate, glutamine, glycine, histidine, hydroxyproline, hydroxyserine, lysine, O-acetyl-
L-serine, ornithine, phenylalanine, proline, serine, threonine, tryptophan, taurine, 
agmatine, canavanine, citruline, ectoine, thenine, xanthine, urea, uric acid, trigonelline, 
GBB, GABA, creatine, creatinine, carnitine, choline-O-sulfate, choline, GB, DMG, 
sarcosine, cadaverine, spermidine, putrescine, UDP-glucose, N-acetyl-glucosamine, N-
acetyl-galactosamine, anthranilate, and PABA. Compounds were prepared in 48-well 
plates (Costar), one compound per well. For carbon-source screen plates, compounds 
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were added at 100 mM in 30 µL for a final concentration of 20 mM. For nitrogen-source 
screen plates, compounds were added at 25 mM in 30 µL for a final concentration of 5 
mM. WT and deletion strains were struck onto LB agar plates and incubated overnight at 
37oC. These were used to inoculate 3 mL of MOPS with 20 mM pyruvate and 5 mM 
glucose, which were incubated at 37oC overnight on a culture wheel. For carbon source 
screening, overnights were collected by centrifugation, washed with 1 mL MOPS, and 
resuspended in MOPS to an OD600 measurement of 0.05. For nitrogen source screening, 
overnights were spun down and washed with 1 mL MOPS minus NH4+ plus 20 mM 
pyruvate, then resuspended in MOPS minus NH4+ plus 20 mM pyruvate to an OD600 
measurement of 0.05. In both cases, 120 µL of resuspended cells were added per well of 
the appropriate plates, which were sealed with sterile, gas-permeable plate film. The 
plates were incubated at 37oC in humidity chambers on a shaker, and OD600 was 
measured at 24 and 48 hours.  
 
3.5.5 Prediction of amino acid mutations resulting in constitutively active GATRs.  
  Understanding of the putative dimerization of GATRs is based off of the crystal 
structure of the N-terminal domain of the SouR ortholog, 3GRA, originating from 
Pseudomonas putida (88, 89). Unpublished data from Graham Willsey at the University 
of Vermont indicated mutations in particular residues of P. aeruginosa SouR that resulted 
in constitutive activation of SouR-regulated genes (Figure 3.7). The N-terminal domain 
of P. aeruginosa SouR was strung onto the 3GRA crystal structure using UCSF Chimera 
(90), which revealed that the constitutive mutations were localized in the putative 
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dimerization domain.  Portions of the N-terminal domain from various GATRs were then 
modeled onto the structure of 3GRA to identify the structurally orthologous residues in 
each GATR, resulting in the predictions contained within Table 3.5. 
 
3.5.6 Generation of complement and constitutive GATR strains. 
  Plasmid tools for attTn7 integration produced by Choi and colleagues (19, 20, 91) 
were used for complementation in both B. thailandensis and P. aeruginosa. For B. 
thailandensis, complementing plasmids based on pUC18T-mini-TN7T-TP or pUC18-
mini-TN7T-Zeo (Table 3.2) were co-transformed with pTNS2 using electroporation and 
subsequently selected on either LB agar plates containing 100 µg/mL trimethoprim or 
Low-salt LB plates (3 g/L NaCl, pH= 7.5 with NaOH) containing 250 µg/mL zeocin. For 
P. aeruginosa, a tri-parental mating strategy was utilized. Briefly, WT or ΔgbdR P. 
aeruginosa PA14 was combined with E. coli S17-1 containing pUC18-mini-TN7T-Gm 
based complement or empty vector and E. coli S17-1 containing pTNS2 in various 
proportions. Prior to conjugation, P. aeruginosa strains were heat-shocked for fifteen 
minutes at 42oC. These mixtures were spotted onto LB plates without antibiotics and 
incubated overnight at 30oC. Spots were scrapped off the plate and re-plated onto 
Pseudomonas isolation agar (PIA) (BD) plates containing 50 µg/mL gentamicin and 
incubated overnight at 37oC. Resistant colonies were subcultured on PIA with 50 µg/mL 
gentamicin and selected clones were screened by PCR.  
 
3.5.7 Growth of strains and RNA extractions.  
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  Putative constitutive complement mutants were grown in tandem with their 
respective deletion strain as a control to avoid potential interference by wild type GATRs 
either through interaction between mutant and wild-type GATRs or competition for DNA 
binding sites. 3 mL MOPS with 20 mM pyruvate and 5 mM glucose cultures were 
inoculated from LB plates and grown on a rotary wheel at 37oC. These overnights were 
pelleted in a table top centrifuge and washed once in 1 mL MOPS media with 20 mM 
pyruvate and resuspended in 1 mL of the same. OD600 measurements were taken so that 
induction cultures could be inoculated at a starting OD600 of 0.3, and these were grown 
for 4 hours at 37oC on a rotary wheel. Inductions were pelleted and resuspended in 800 
µL of 95oC RNAzol RT (Sigma) whereupon they were frozen at -80oC after five minutes 
at room temperature.  
  To continue the RNA extraction, samples were thawed and 400 µL water was 
added to each sample and vortexed vigorously, followed by a room temperature 
incubation for fifteen minutes. Samples were centrifuged at 10,000 x g for fifteen minutes 
at 4oC, and the supernatant was transferred to a clean microcentrifuge tube. The 
supernatant was then combined with 100% molecular grade ethanol at a 1:1 ratio, mixed, 
and applied to Zymo-Spin IIC columns (Zymo Research (ZR)).  Columns were 
centrifuged for thirty seconds at 10,000 rpm, washed with 400 µL direct-zol prewash 
(ZR), then washed with 700 µL and 400 µL of wash buffer (ZR). The columns were 
further centrifuged to dryness for two minutes at 10,000 rpm, then RNA was eluted using 
100 µL RNase-free water into a clean microcentrifuge tube.  
  In order to remove DNA, 11 µL of 10x DNase I Buffer and 1 µL of RNase-free 
DNase I (New England BioLabs) were added to each sample and incubated at 37oC for 
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twenty minutes. An additional 1 µL of RNase-free DNase I was added to each sample 
and the incubation at 37oC was continued for another twenty minutes. Samples were then 
further processed using RNeasy mini kit (Qiagen) per the manufacturer’s protocol sans 
further DNase I steps. Resulting RNA was quantified by NanoDrop (Thermo, ND-1000). 
 
3.5.8 Microarray analysis of constitutive mutants. 
  Prior to microarray analysis, RNA was quantified using Qubit (Thermofisher) and 
assayed for quality on a Bioanalyzer using the RNA 6000 pico kit (Agilent). cDNA was 
prepared from total RNA using the Ovation Pico WTA System V2 (NuGEN). Samples 
were applied to custom GeneChips (Affymetrix) designed for P. aeruginosa PA14, B. 
thailandensis E264, Klebsiella pneumoniae, and Stenotrophomonas maltophilia genomes. 
Runs were analyzed with Expression Console and Transcriptome Analysis Console v3.0 
provided by Affymetrix.   
 
3.5.9 cDNA synthesis and quantitative real-time PCR.  
  cDNA was generated using the SuperScript First-Strand Synthesis System for RT-
PCR (Invitrogen), following the manufacturer’s protocol for transcripts with high GC 
content. Transcripts were amplified using 1 µL NS5 primer and 2.5 µL of 100 ng/µL 
RNA per sample. 
  Reactions for qRT-PCR consisted of 7.5 µL Q5 High-Fidelity 2x Master mix 
(NEB), 1.6 µL 1x SYBR Green I (Thermofisher), 0.2 µL of each of the two 20 µM 
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primers used, 2.75 µL water, 0.75 µL DMSO, and 2 µL of cDNA. qPCR was performed 
using a BioRad QFX96 qPCR system. Samples were compared by calculating ΔΔCt 
values.  
 
3.5.10 Growth of I0685 deletion and complemented strains in the presence of 
formaldehyde. 
  ΔI0685, ΔI0685 att::I0685 WT, and ΔI0685 att::I0685 N32G strains were 
constructed in a B. thailandensis ΔII1870 background to minimize the compensatory 
effects of other formaldehyde detoxification systems. Strains were grown overnight in 
MOPS minimal media supplemented with 20 mM pyruvate and 5 mM glucose at 37oC. 
Overnights were pelleted and washed 1x with 1 mL MOPS with 20 mM pyruvate, and 
resuspended in the same. Resuspended cells were diluted to an OD600 of 0.05 in either 
MOPS plus 20 mM pyruvate or MOPS plus 20 mM pyruvate at 0.75 mM formaldehyde. 
Cells were incubated at 37oC for 24 hours in a 24 well plate, 500 µL per well. 
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3.6 Chapter 3 Figures 
Figure 3.1 – GATR phylogeny based on full-length. 
All full-length GATR amino acid sequences from B. thailandensis E264, B. 
pseudomallei, B. mallei, B. cenocepacia, PyrG (CTP synthetase) from E. coli, and FtrA 
orthologs from E. coli, C. crescentus, and Y. enterocolitica were aligned and a maximum 
likelihood, unrooted phylogenetic tree was constructed using 500 bootstrap replicates. 
Bootstrap confidence values are displayed at branches. 
 
Figure 3.2 – GATR phylogeny based on GATase1-like domain. 
The amino acid sequences for bioinformatically predicted GATase1-like domains of the 
GATRs of B. thailandensis E264, B. pseudomallei, B. mallei, B. cenocepacia, PyrG (CTP 
synthetase) from E. coli, and FtrA orthologs from E. coli, C. crescentus, and Y. 
enterocolitica were aligned and a maximum likelihood, unrooted phylogenetic tree was 
constructed using 500 bootstrap replicates. Bootstrap confidence values are displayed at 
branches. 
 
Figure 3.3 – Growth of deletion strains on sole carbon sources. 
The growth of WT and deletions strains on sole carbon sources at 37oC and was 
monitored by measuring OD600. The heat map represents averaged readings between the 
24 and 48 hour time points. Darker purple indicates a higher optical density.  
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Figure 3.4 – Growth of deletion strains on sole nitrogen sources.  
The growth of WT and deletions strains on sole nitrogen sources at 37oC and was 
monitored by measuring OD600. The heat map represents averaged readings between the 
24 and 48 hour time points. Darker purple indicates a higher optical density.  
 
Figure 3.5 –II1850 (cdhR) regulates carnitine catabolism. 
(A) The synteny of genes divergent from II1850 in B. thailandensis E264 and cdhR in P. 
aeruginosa PAO1 is compared. The divergent genes represent clear orthologs when 
sequences are compared and their arrangement is conserved between the two species. (B) 
B. thailandensis E264 att::vector (WT) is able to grow on carnitine as a sole carbon 
source on MOPS minimal media plates. ΔII1850 att::vector is unable to utilize carnitine 
as a sole carbon source under the same conditions. The complementation of II1850 at the 
attTn7 site, under the control of its native promoter, restores the ability to grow on 
carnitine as a sole carbon source. This suggests that II1850 is an ortholog of CdhR and 
regulates the divergent genes in a similar manner.  
 
Figure 3.6 – I1774 (argR) regulates arginine catabolism. 
(A) Genes in the neighborhood of I1774 in B. thailandensis E264 are bioinformatically 
predicted to be involved in the catabolism and transport of arginine, similarly to those in 
the neighborhood of argR in P. aeruginosa PAO1. The synteny of genes is not perfectly 
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conserved between the species, but the similarity of predicted function is suggestive that 
ArgR and I1774 are orthologous. (B) B. thailandensis E264 att::vector (WT) is able to 
grow on arginine as a sole carbon source on MOPS minimal media plates. ΔI1774 
att::vector is unable to utilize arginine as a sole carbon source under the same conditions. 
This defect may be complemented by placing the I1771-4 operon at the attTn7 site.  
 
Figure 3.7 – Constitutive mutations in P. aeruginosa SouR overlaid on 3GRA. 
The amino acid sequence of SouR from P. aeruginosa was overlaid on the crystal 
structure of its ortholog in P. putida, 3GRA. Constitutive mutants of SouR were 
sequenced and cognate amino acids in 3GRA were identified based on the overlay. 
Highlighted mutations are as follows: P41S,T (red), D48G (orange), D76N (green), and 
P185S (blue). 
 
Figure 3.8 – Constitutive GbdR rescues growth on choline. 
Similarly to the previously published ability of wild type gbdR to complement growth 
defects of ΔgbdR in P. aeruginosa on choline as a sole carbon source, ΔgbdR att::gbdR 
E36G was able to rescue growth. This suggests that GbdR E36G is capable of folding 
properly and inducing GbdR controlled promoters.  
 
Figure 3.9 – I0685 represses resistance to formaldehyde.  
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ΔII1870 att::vector is capable of growing in the presence of 0.75 mM formaldehyde. 
Deletion of ΔI0685 causes a slightly increased amount of growth, while complementation 
of the deletion with WT I0685 slightly reduces the amount of growth compared to wild 
type. Complementation of the deletion with I0685 N32G results in a striking decrease in 
the ability to tolerate formaldehyde compared to any of the other strains. Data is 
representative of three independent experiments.  
 
Figure 3.10 – II1912 synteny in other Burkholderia.  
Comparison of synteny for II1912 orthologs in multiple strains of B. thailandensis and 
one representative strain of B. pseudomallei. Schematic is approximate.  
Figure 3.11 – FtrA is a potential regulator of cyanide detoxification. 
(A) Alignment of amino acid sequences done as described for Figure 3.1, but nodes other 
than FtrA are collapsed for clarity. The FtrA node is highlighted in red. (B) Gene 
arrangement of II1760 and II1761. Synteny is identical for other Burkholderia species 
containing obvious II1760 orthologs. (C) Cyanide detoxification reaction catalyzed by 
rhodanese.  
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3.7 Chapter 3 Tables 
Table 3.1 – Strain list. 
Table 3.2 – Plasmid list.  
Table 3.3 – Primer list. 
Table 3.4 – Burkholderia GATR homologs based on gene synteny.  
This chart uses observed synteny and bioinformatic predictions of genes adjacent to 
GATRs in B. thailandensis, B. pseudomallei, B. mallei, and B. cenocepacia in an attempt 
to predict potential orthologs. It also denotes if the divergent gene is predicted to be a DJ-
1 family member protein, a common feature of many putative GATRs.  
Table 3.5 – Predicted constitutive mutants.  
Predictions of residues that, when altered, may perturb the dimerization of the GATR and 
lead to constitutive activity.  
 
Table 3.6 –GbdR E36G microarray results. 
GbdR E36G induces expression of known GbdR regulon members in the absence of 
ligand. Cutoffs for data displayed are: fold effect ≥ 2 or ≤ -2, p value ≤ 0.05. Genes 
related to GB transport or catabolism are highlighted.  
 
Table 3.7 – I0685 N32G microarray results. 
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I0685 N32G downregulates expression of the glutathione independent formaldehyde 
dehydrogenase and its associated esterase. Cutoffs for data displayed are: fold effect ≥ 5 
or ≤ -5, p value ≤ 0.05. 
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CHAPTER 4:  
 
DISCUSSION AND FUTURE DIRECTIONS 
 
4.1 A brief summary of progress. 
  The first contribution of this work is the generation of an alternative model for the 
regulation of glycine betaine (GB) catabolism. In this new model, we identified multiple 
AraC-family transcriptional regulators (ATRs) and characterized their phenotypes and 
target operons. The development of a model complementary to our original P. aeruginosa 
model provides the opportunity for to compare and contrast in order to gain new 
information about each. As part of this process, we identified and characterized three 
ATRs in this pathway that are structurally related to the GATase1 enzymes, and represent 
a subfamily of ATRs referred to as Glutamine amidotransferase1 (GATase1)-containing 
AraC-family transcriptional regulators (GATRs). The new regulatory model represents a 
scheme that better reflect the regulation found in Burkholderia, and may allow for 
assumptions of more distantly related bacteria that also possess these GATRs.  
  The second major contribution is the further characterization of GATRs as a 
family by presenting a methodology for perturbing the dimerization domain to yield 
constitutively active, ligand-independent mutants. This allows for the identification of 
target genes, whose potential functional predictions for which may inform us about the 
metabolic process that an unknown GATR is involved in and potentially ligands to which 
the GATR responds. Utilizing this method we identified I0685, a GATR that regulates 
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formaldehyde detoxification. The discovery of a GATR that functions as a repressor 
challenges our initial hypothesis that GATRs function strictly as activators, and opens the 
possibility that ligands for these regulators may not all be amine-containing compounds.  
   Simultaneously, these advancements have directly expanded our knowledge of the 
basic biology B. thailandensis. Several questions remain and our work has led to 
additional questions.   
 
4.2 Remaining questions about the regulation of glycine betaine catabolism in B. 
thailandensis. 
4.2.1 What are the possibilities for GbdR1/GbdR2 interaction? 
 We observed that GbdR1 and GbdR2 are both required for optimal induction of 
genes required for the transport and catabolism of GB. Furthermore, both GATRs can 
bind to the promoter region of the large GB catabolic operon (Figures 2.1, 2.5) (1). The 
presence of GbdR1 is an absolute requirement for expression of GbdR2 and GbdR2 
increases the expression of GbdR1 (Table 2.1). This suggests that there is some manner 
of interaction between these two GATRs. However, the experiments described here were 
not sufficient to determine the particular nature of this relationship.  
  There are several possible explanations for the presence of two orthologs in this 
system. It is possible that there are unidentified half sites or overlapping binding sites for 
GbdR2 within the portion of promoter used in our experiments. Such sites might allow 
GbdR2 to regulate expression of GbdR1, as opposed to other ATRs which have been 
shown to autoregulate their own expression (2-4). Multiple binding sites might provide 
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an explanation for the banding pattern seen in electromobility shift assays incorporating 
GbdR2 (Figure 2.5B).  
  We also observed that the N-terminal arm of GbdR2 is slightly longer than other 
GATR N-terminal sequences. The presence of a longer N-terminal arm might offer an 
opportunity for regulation either through protein degradation or perhaps as a mechanical 
sensor for osmotic stress where its structure may be influenced by the physiological state 
of the cell (5, 6). Perhaps the arm affects the dimerization state by altering structural 
conformation as it does in the case of AraC (7). These possibilities might allow GbdR2 to 
act as a licensing factor for catabolism of GB under favorable conditions while 
preventing its breakdown during osmotic stress. 
  In order to determine the relationship between GbdR1 and GbdR2, there are 
several relatively simple approaches we could take. The first is to more carefully 
determine the binding site of each regulator. Our initial attempts to achieve this through 
DNAase footprinting assays were unsuccessful, but there are many adjustments on the 
technique that could be applied. Alternatively, ChIP-seq might provide insights by 
identifying new target promoters, cumulatively from which binding sites and half sites 
which we were not able to detect might be derived (8).  
  The challenge in working with ATRs biochemically is thought to be due to a 
number of factors including their ability to oligomerize, potential folding issues when 
overexpressed protein is unbound, and potential non-specific binding to DNA that 
disrupts cell function during overexpression (9). However, much of this difficulty can be 
abrogated by expressing the domains individually, and focusing on just the C-terminal 
domain to determine the target binding site (10, 11). We could also repeat our RNA-seq 
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experiments under osmotically stressful conditions to discern if the apparent regulons of 
these regulators changes.  
 
4.2.2 Likely influences on the regulation of GB catabolism in B. thailandensis that 
remain unaddressed. 
  Although the focus of our study has been on the GATRs involved in the 
regulation of GB catabolism, there are additional points of regulation in the pathway 
based on the model in P. aeruginosa that are likely to impact it. The breakdown of 
choline into GB is accomplished by the products of the betBA genes in P. aeruginosa, 
which are regulated by the TetR-family repressor, BetI (12, 13). These genes have also 
been identified in B. thailandensis, but it is not known if BetI impacts genes beyond 
betBA in this organism (14). Recently the expression of gbdR in P. aeruginosa was found 
to be under the direct control of BetI, as well as the global regulators NtrC and CrbB 
responsible for accessory nitrogen and carbon catabolism respectively (15). Notably, 
CrbB has also been shown to be necessary for the expression of the operon containing the 
GATR argR in P. aeruginosa (16). Nucleoid-associated proteins like H-NS, which are 
functionally similar to histones, are increasingly appreciated to play an important 
regulatory role in gene expression and have been shown to compete with ATRs for 
binding sites (17-19). Though not described, this is most certainly the case for B. 
thailandensis as well and it is possible that nucleoid-associated proteins impact the 
regulation of the GB catabolic pathway.  
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  Exploration of the additional regulators impacting this pathway could benefit 
from several approaches. First, the individual characterization of the binding sites of 
these regulators to enable the bioinformatic prediction of target promoters. Alternatively, 
deletion strains could be generated and used in combination with reporter plasmids 
similarly to our previous strategy to determine if they impact the expression of the GB 
catabolic operon (1). The findings could then be verified through ChIP to confirm 
physical interaction between the predicted binding sites and regulator. However, this 
approach might be hindered by the degree to which these global regulators can impact the 
cell and that may obfuscate the results. 
 
4.2.3 How important is GB as an osmolyte and are there pools of related molecules 
in B. thailandensis? 
  Despite our focus on the importance of the GB catabolic pathway and our lab’s 
past interest in osmoprotection and molecular pools of osmolytes, we have not focused 
specifically on osmoprotection in B. thailandensis. The particular characteristics that 
predispose a given molecule to lend the cell resistance to osmotic stress, or for that matter 
barometric or thermal stress, are somewhat abstract. It is clear that such a compound must 
be a compatible solute, that is, the cell must be able to accumulate the molecule to high 
levels without disrupting the other biological processes and pathways necessary for life 
(20). Ideally, the amount of these molecules would be readily controlled by means of 
transport or metabolic flux to compensate for a rapidly changing environment.  
  Typically for many bacteria, a sudden increase in hypertonic osmotic stress results 
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in the rapid uptake of K+ and production of glutamate, an often less than ideal 
countermeasure (21). The cell then accumulates and switches to the preferred osmolytes, 
while reducing the intracellular level of glutamate (22). Beyond GB and closely related 
compounds, other osmolytes found to be used by bacteria include trehalose, proline, 
ectoine, dimethylsulfoniopropionate, and others (23-28).  
  Previously our lab has utilized 13C nuclear magnetic resonance to examine the 
presence of molecular pools of choline and GB present during conditions of osmotic 
stress in different proteobacteria.  As part of these experiments Burkholderia cepacia was 
observed to maintain a small choline pool and a larger GB pool, possibly functioning as a 
hedge against osmotic stress (29). B. thailandensis almost certainly maintains similar 
pools due to this being shown in B. cepacia and in addition to many other proteobacteria, 
but it has not been shown empirically. Preliminary experiments have also shown that B. 
thailandensis grown on choline is more tolerant to salt stress than when grown on 
pyruvate (unpublished). Presumably, these findings and the significant conservation of 
pathways resulting in the production of GB in Burkholderia indicate that examining GB 
induced osmoprotection in B. thailandensis would yield the same results. However, 
understanding the molecular mechanisms behind osmoprotection in B. thailandensis, and 
by extension its close relatives B. pseudomallei and B. mallei, will address pertinent 
biological questions. For instance, how does B. pseudomallei manage to endure 
environmental stress as the seasons changes from rainy to dry where it is endemic (30, 
31)? Additionally, might GB related metabolism be important for interaction with plants 
(33)? 
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4.2.4 How closely is the transport and catabolism of choline-O-sulfate linked to 
GbdR1 and GbdR2? 
  Choline-O-Sulfate (CS) catabolic operon is expressed in the presence of choline, 
dependent on the presence of both GbdR1 and GbdR2 (1). CS is used as a mechanism for 
sulfur storage in fungi, as well as an osmolyte by many plants (34, 35). Certain members 
of the Plumbaginaceae (a family of salt tolerant plants) preferentially utilize CS and β-
alanine betaine as osmoprotectants over GB, likely due to the utility of using the 
generation of CS as a means to detoxify sulfur in the salt marsh environment (36). Many 
bacteria can utilize CS as an osmolyte or indirectly by converting it into GB, and in the 
case of B. thailandensis, subsequently using it as a carbon and nitrogen source (37, 38). 
B. thailandensis possess genes for the transport and catabolism of CS located near the 
genes involved in the catabolism of GB. These genes encode a choline sulfatase (betC), a 
CS substrate binding periplasmic transport protein (betD), a sulfate transporter (betE), 
and a divergently transcribed LysR-family transcriptional regulator (betR). This gene 
arrangement is broadly conserved in Burkholderia, particularly in the closely related B. 
pseudomallei and B. mallei. In Pseudomonas species, BetR has been shown to positively 
activate transcription of this operon in the presence of CS, but not choline or GB, and to 
negatively repress its own transcription in the absence of CS (39).  
  We have shown that B. thailandensis can utilize CS as either a sole carbon or 
nitrogen source (Figures 3.3 and 3.4). Studies from our own lab on the regulons of GbdR-
like GATRs in P. aeruginosa have not suggested any such regulatory link exists between 
the CS catabolism and any of the GATRs (40, 41). It is conceivable that the upregulation 
of CS-related genes is due to read through transcription of the large GB catabolic operon, 
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which might continue to include the CS catabolic operon despite being interrupted by 
purU-2 and betR being transcribed in the opposite direction between the two (Figure 
2.1C). Another possibility is that the CS catabolic operon or betR are regulated directly 
by either GbdR1 or GbdR2. The answer to this could be tackled by simple genetic 
techniques already utilized in our lab and would make an excellent project for an 
undergraduate.  
  The data obtained thus far suggest that B. thailandensis and other Burkholderia 
may have a more complex regulatory response to GB than initially appreciated, in a sense 
anticipating the environmental presence of CS through the presence of a downstream 
metabolite. The presence of pathways that utilize CS and related metabolites is logical in 
a bacterium that often resides in soil with an association to plants and fungi. The 
utilization of CS may provide an additional clue to the particular environmental niche 
where B. thailandensis and B. pseudomallei reside, given that its particular environmental 
reservoir is still unknown as discussed in Chapter 1.  
  
4.2.5 The absence of SouR in B. mallei and potential effects on GB catabolism. 
  B. mallei lacks a sequence ortholog for SouR, the GATR that is responsible for 
the regulation of sarcosine catabolism, a downstream portion of the glycine betaine 
utilization pathway in B. thailandensis and P. aeruginosa (1, 40). An ortholog for the α-
subunit of sarcosine oxidase is present in twenty seven out of forty two sequenced B. 
mallei strains while the γ-subunit ortholog can only be found in four of those strains (42). 
Traces of the remaining sarcosine oxidase subunits and sdaA cannot be identified at all. 
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Tellingly, putative transposases are uniquely located adjacent to the α-subunit suggesting 
that the sarcosine oxidase operon was truncated in the process of genetic reduction. This 
suggests that unlike B. pseudomallei and B. thailandensis, B. mallei is unable to utilize 
GB or its catabolites as a carbon or nitrogen source due to a probable inability to degrade 
sarcosine.  
  Despite missing this piece of the pathway, B. mallei maintains orthologs for 
GbdR1, GbdR2, and CdhR (Table 3.4, Figures 3.1 and 3.2). Also maintained are the 
operons that these GATRs regulate. B. mallei is considered to be derived directly from a 
particular isolate of B. pseudomallei that underwent significant genetic reduction due the 
proliferation of insertion sequence (IS) elements from transposons and phages (43-45). 
This evolution and reduction continue through genomic recombination due to homology 
between IS elements (46). This genomic reduction likely led to B. mallei becoming an 
obligate parasite of mammalian cells, particular equines (47). It is possible that the 
transport systems for carnitine, choline, and GB retain importance for survival due to the 
role of GB as an osmoprotectant, but the acquisition of these compounds for usage as 
carbon and nitrogen sources is diminished due to the host environment being rich in other 
nutrient sources. It is possible that B. mallei possesses an alternative pathway for 
sarcosine degradation that would otherwise complete the larger pathway, but none are 
obvious.  
  Although B. mallei has never been isolated from the environment and is 
considered an obligate pathogen, it is possible to cultivate it under laboratory condition in 
minimal media (48). Thus it may be surprisingly simple to test if sarcosine may be 
utilized. Methods for genetic manipulation have been developed for B. mallei (49), and 
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many animal models for virulence have been published (50-54). It may be possible to use 
these methods to discern if carnitine or GB transport and catabolism play a role in fitness 
during B. mallei infection.  
 
4.3 Deciphering the mechanism of GATRs 
4.3.1 How do GATRs interact with RNA polymerase? 
  While most ATRs have been shown to function as activators, it remains unclear 
how GATRs that function as activators interact with RNA polymerase, if at all. 
Activators may function through a number of mechanisms including class I and II 
activation, which involve direct interaction with RNA polymerase (55). In class I 
activation, the activator interacts with the α subunit C-terminal domain of RNA 
polymerase. In class II activation, the activator sits adjacent to the -35 site and interacts 
with the σ subunit. Additional mechanism include class III activation where multiple 
activators interact with different subunits of RNA polymerase and activators that change 
the promoter conformation such that RNA polymerase can recognize the -10 and -35 
elements (56). Different ATRs have previously shown to act as class I or class II 
activators (57-60). Based on the position of the CdhR binding site relative to the caiX 
promoter in P. aeruginosa (61), it is most likely that GATRs are class I activators. 
  The type of activation may be ascertained in several different ways. Showing 
interaction by immunoprecipitation of RNA polymerase components would be 
informative.  Improvements in our understanding of promoters targeted by GATRs may 
aid our understanding by determining the positioning of various GATRs with respect to 
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other elements of the promoter. Performing 5’ rapid amplification of cDNA ends (RACE) 
to determine the actual transcriptional start sites of GATR targeted promoters and 
determining GATR binding sites as previously mentioned would readily accomplish this.  
  Because we already have some evidence that I0685 functions as a repressor 
(Figure 3.8, Table 3.7), it is possible that not all GATRs actually interact with RNA 
polymerase. However, it is still possible that I0685 N32G is simply locked in a repressive 
conformation. The location of binding sites within promoters often dictates whether a 
regulator functions as a repressor or an activator and can differ for the same regulator 
between promoters as with the ATR, MarA (62). However, it is possible that some 
findings will be transferable among more closely related GATRs, particularly those 
within the GbdR1 clade that appear to function specifically as activators (Figures 3.1 and 
3.2). 
 
4.3.2 A novel mechanism for ATR function.  
  The mechanism of GATRs, similar to other ATRs, likely revolves around a 
conformational change in the dimer to achieve either activation or de-repression. For 
GATRs this conformational change is potentially derived from homology to GATases, 
which depend on dimerization for creation of an ammonia channel and subsequent 
conformation change to open the channel and transfer the ammonia to an associated 
synthase (63). Additional analysis of the 3GRA structure and the generation of new 
crystal structures in the presence and absence of ligand may provide insight into whether 
conformational changes from GATases are likely to be conserved in GATRs.  We could 
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also incorporate our constitutive GATR mutants into these experiments to determine if 
the crystal structures, and subsequently the conformation of the predicted dimer, are 
altered.  
  In other ATRs such as AraC, changes in conformation arise in part from 
interaction of the N-terminal arm with bound ligand (7, 64-66). Due to the unconserved 
nature of the N-terminal arm in GATRs, it is unclear if it serves a similar function. N-
terminally affinity tagged GATRs have been shown to bind DNA targets in vitro (1, 40, 
41, 61), which might be expected to impact the functionality of the arm and subsequently 
the DNA binding properties of the protein. Future studies should employ strains with 
deletions of the N-terminal arm to help determine if the arms is a critical component of 
known GATRs. These apparent differences between GATR mechanism from previously 
described mechanisms of ATRs offers a new, additional model for ATR function.  
 
4.3.3 The potential functions of unknown GATRs.  
  Several GATRs are divergently transcribed from putative DJ-1/Pfp1family 
proteins (Figure 1.7, II0513 and II1912), a family which includes GATase1 domain 
containing proteins. It is tempting to speculate if homology between the GATR and 
adjacent protein product might reflect commonalities between the ligand for the regulator 
and the substrate for the enzyme.  One of these adjacent genes in B. thailandensis, 
II0514, has recently been bioinformatically predicted to be involved in the degredation of 
caprolactam (42). Caprolactam is a cyclic amide used in the production of Nylon 6 and 
may be used as a carbon source by some bacteria (67).  
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  Other GATRs of unknown function are also divergently transcribed from their 
likely regulatory targets. II2197 is divergently transcribed from a predicted O-
acetylserine sulfhydrylase, an enzyme that generates L-cysteine and acetate from 
bisulfide and O-acetyl-L-serine (68). Although our carbon and nitrogen screens included 
O-acetyl-L-serine (Figure 3.3, 3.4), it is possible that there is no efficient transporter 
specific for O-acetly-L-serine and some bacteria are known to contain multiple O-
acetylserine sulfhydrylases (69). II0282 is divergently transcribed from a gene encoding a 
predicted isochorismatase-family protein. Isochorismatase family proteins include a 
GATase1 domain and catalyze the conversion of chorismate to 2,3-dihydroxybenzoate 
and pyruvate. Chorismate itself is an important precursor for aromatic amino acids, 
folate, vitamin K, salicylic acid, and siderophores (70, 71). A description of the 
relationship between II1760 and rhodanese is described in chapter 3 and between I1350 
and capsule genes in Appendix A. 
  These potential functions greatly broaden the scope of metabolic processes which 
GATRs are involved in. These insights also point to additional compounds to test the 
GATR deletion strains against in future variations of our carbon- and nitrogen-source 
screens (Figures 3.3, 3.4).   
 
4.4 Concluding remarks. 
 B. thailandensis has proven to be an excellent model for the exploration of 
GATRs and we have identified the function of roughly half the GATRs in this organism. 
Importantly, we have gained insight into a GATR outside of the GbdR clade (Figure 4.1). 
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This has challenged some of our initial assumptions about this family of regulators, as we 
now understand they may act as either activators or repressors, and may not be limited to 
amine-containing compounds as ligands. With this new information, we can refine our 
methodology for generating constitutive mutants, gain understanding of the remaining 
GATRs in B. thailandensis, and hopefully unravel the molecular mechanisms behind 
GATR function. 
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4.5 Chapter 4 Figures 
Figure 4.1 – GATRs of known function in B. thailandensis. 
This phylogenetic tree was constructed as described in chapter 3 of this thesis. GATRs 
with known functions are highlighted in purple. While most of the described GATRs are 
clustered together, notably I0685 is located on the far side of the tree. Thus, perhaps new 
insights into the remaining GATRs may be gleaned from the differences we find between 
the GbdR1-like clade and I0685.  
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Wheelis, M., L. Rózsa, and M. Dando. 2006. Deadly cultures : biological weapons since 
1945. Harvard University Press, Cambridge, Mass. xi, 479 p. pp. 
White, R.F., L. Kaplan, and J. Birnbaum. 1973. Betaine-homocysteine transmethylase in 
Pseudomonas denitrificans, a vitamin B 12 overproducer. J Bacteriol. 113:218-
223. 
Whiteley, L., T. Meffert, M. Haug, C. Weidenmaier, V. Hopf, K. Bitschar, B. Schittek, C. 
Kohler, I. Steinmetz, T.E. West, and S. Schwarz. 2017. Entry, intracellular 
survival and multinucleated giant cell-forming activity of Burkholderia 
pseudomallei in human primary phagocytic and non-phagocytic cells. Infect 
Immun. 
Whitmore, A.K., CS. 1912. An account of the discovery of a hitherto undescribed 
infectious disease among the population of Rangoon. Ind Med Gaz. . 46:262–267. 
Wilcox, G., and P. Meuris. 1976. Stabilization and size of araC protein. Molecular & 
general genetics : MGG. 145:97-100. 
Wildermuth, M.C., J. Dewdney, G. Wu, and F.M. Ausubel. 2001. Isochorismate synthase 
is required to synthesize salicylic acid for plant defence. Nature. 414:562-565. 
Willsey, G.G., and M.J. Wargo. 2015. Sarcosine catabolism in Pseudomonas aeruginosa 
is transcriptionally regulated by SouR. J Bacteriol. 
Winsor, G.L., E.J. Griffiths, R. Lo, B.K. Dhillon, J.A. Shay, and F.S. Brinkman. 2016. 
Enhanced annotations and features for comparing thousands of Pseudomonas 
genomes in the Pseudomonas genome database. Nucleic acids research. 44:D646-
653. 
Winsor, G.L., B. Khaira, T. Van Rossum, R. Lo, M.D. Whiteside, and F.S. Brinkman. 
2008. The Burkholderia Genome Database: facilitating flexible queries and 
comparative analyses. Bioinformatics. 24:2803-2804. 
Withatanung, P., N. Chantratita, V. Muangsombut, N. Saiprom, G. Lertmemongkolchai, 
J. Klumpp, M.R. Clokie, E.E. Galyov, and S. Korbsrisate. 2016. Analyses of the 
Distribution Patterns of Burkholderia pseudomallei and Associated Phages in Soil 
Samples in Thailand Suggest That Phage Presence Reduces the Frequency of 
Bacterial Isolation. PLoS neglected tropical diseases. 10:e0005005. 
Wood, J.M. 1988. Proline Porters Effect the Utilization of Proline as Nutrient or 
Osmoprotectant for Bacteria. J Membrane Biol. 106:183-202. 
Wood, J.M. 2011. Bacterial osmoregulation: a paradigm for the study of cellular 
homeostasis. Annual review of microbiology. 65:215-238. 
Woods, D.E., J.A. Jeddeloh, D.L. Fritz, and D. DeShazer. 2002. Burkholderia 
thailandensis E125 harbors a temperate bacteriophage specific for Burkholderia 
mallei. J Bacteriol. 184:4003-4017. 
Wu, M., and R. Schleif. 2001. Strengthened arm-dimerization domain interactions in 
AraC. The Journal of biological chemistry. 276:2562-2564. 
188 
 
Wuthiekanun, V., M.D. Smith, D.A. Dance, A.L. Walsh, T.L. Pitt, and N.J. White. 1996. 
Biochemical characteristics of clinical and environmental isolates of Burkholderia 
pseudomallei. Journal of medical microbiology. 45:408-412. 
Yabuuchi, E., Y. Kosako, H. Oyaizu, I. Yano, H. Hotta, Y. Hashimoto, T. Ezaki, and M. 
Arakawa. 1992. Proposal of Burkholderia gen. nov. and transfer of seven species 
of the genus Pseudomonas homology group II to the new genus, with the type 
species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov. Microbiol 
Immunol. 36:1251-1275. 
Yang, J., M. Tauschek, and R.M. Robins-Browne. 2011. Control of bacterial virulence by 
AraC-like regulators that respond to chemical signals. Trends in microbiology. 
19:128-135. 
Yu, Y.T., H.S. Kim, H.H. Chua, C.H. Lin, S.H. Sim, D.X. Lin, A. Derr, R. Engels, D. 
DeShazer, B. Birren, W.C. Nierman, and P. Tan. 2006. Genomic patterns of 
pathogen evolution revealed by comparison of Burkholderia pseudomallei, the 
causative agent of melioidosis, to avirulent Burkholderia thailandensis. BMC 
microbiology. 6. 
Zachowski, A. 1993. Phospholipids in animal eukaryotic membranes: transverse 
asymmetry and movement. The Biochemical journal. 294 ( Pt 1):1-14. 
Zalkin, H. 1993. The amidotransferases. Adv Enzymol Relat Areas Mol Biol. 66:203-309. 
 
 
 
189 
   Appendix A - Biofilm formation in Burkholderia thailandensis. 
 
A.1 Introduction. 
  Our previous investigation into the GATRs GbdR1, GbdR2, and SouR included 
an RNAseq, which included a tantalizing change in expression of yet another GATR and 
the adjacent operon (1). This GATR, I1350, exhibited changes in expression in the same 
range as the adjacent operon, which it may be a part of and we hypothesized that it might 
regulate. This particular operon is one of the major capsule operons in B. thailandensis, 
and the potential for a GATR to impact capsule expression and a possible connection 
with other GATRs piqued our curiosity.  
  B. pseudomallei possesses four major capsular polysaccharide gene clusters (CPS 
I-IV), of which it shares three with B. thailandensis. Notably missing from B. 
thailandensis but present in B. mallei, is CPS-I.  CPS-I is considered an important 
virulence determinant for both B. pseudomallei and B. mallei because it reduces the 
efficiency of opsonization in the blood stream, thus reducing phagocytosis (2-4). 
Expression of CPS-III is increased in water, and may be associated with the ability of B. 
pseudomallei and B. mallei to persist in pure water for extended durations (5). CPS-II and 
CPS-IV (which is adjacent to I1350 and the focus of our interest here) have no obvious 
effect on virulence and their roles are currently unknown (6). In addition to these, there 
are several smaller gene clusters relating to exopolysaccharide production, modification, 
and transport, some of which have been shown to correspond to biofilm production in B. 
pseudomallei (7). Thus far, current studies of the major CPS and potential link to biofilm 
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formation are currently inconclusive since they may provide some redundant 
functionality (8). 
  The perturbation of genes that affect the outer-most layer of the cell and 
consequently biofilm formation was an attractive thread to pull. Like many other bacteria, 
B. thailandensis and its relatives are known to form biofilms that contribute to resistance 
against drugs, desiccation, and predation (9). Therefore, we performed a series of 
experiments to examine potential morphological and biofilm phenotypes in our deletion 
strains.  
 
A.2 Methods. 
 
Construction of strains. The method of construction for these strains has been previously 
published (1), or described elsewhere in this thesis. Briefly, as per Thongdee et al. (10), 
primers were designed to amplify regions upstream and downstream of the region 
targeted for deletion. In tandem, a trimethoprim resistance marker enclosed by FLP 
recombinase sites was amplified with twenty base pair regions on the ends with 
homology to the amplified upstream and downstream fragments. Splice overlap extension 
PCR was used to combine these fragments. Wild type B. thailandensis was grown 
overnight in DM media to induce natural competence, and were pelleted and combined 
with the splice overlap extension amplified product. Homologous recombination resulted 
in the generation of deletion strains that were selected on LB plates containing 100 
µg/mL trimethoprim. The trimethoprim resistance marker was removed by transforming 
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the trimethoprim resistant deletion strains with pFLPe2 by electroporation. pFLPe2 is a 
plasmid expressing FLP recombinase under the control of a rhamnose-inducible promoter 
as described in Choi et al. (11). After selecting transformants on LSLB plates with 0.2% 
rhamnose and 250 µg/mL zeocin incubated at 30oC, and subculturing them a second time 
on the same type of plate, they were struck for isolation on standard LB plates and grown 
at 42oC overnight in order to cure pFLPe2, which possesses a temperature sensitive 
origin. Colonies were then plated onto LB incubated at 37oC, LSLB with 250 µg/mL 
zeocin incubated at 30oC overnight to test for curing of pFLPe2, and LB with 100 µg/mL 
trimethoprim incubated at 37oC overnight to test for absence of the trimethoprim 
resistance marker. Trimethoprim sensitive deletion strains were confirmed by PCR and 
saved. 
 
Spot plating and microscopy. Strains were struck out onto LB agar plates from -80oC 
stocks and incubated overnight at 37oC. For each strain, 3 mL LB broth was inoculated 
and incubated overnight at 37oC. Strains were diluted to an OD600 of 0.25 using LB 
broth, then 5 µL of each was spotted onto an R2B plate. Spots were allowed to dry for up 
to thirty minutes at room temperature before flipping the plate and incubating overnight 
at 37oC. Photographs of resulting macro-colonies were taken using a Leica MZ16 F 
stereomicroscope and Leica DC500 CCD camera at the University of Vermont 
Microscopy Imaging Center.  
 
Biofilm assay. The methodology for this assay was adapted from the popular microtiter 
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biofilm assay popularized by George O’Toole’s lab at Dartmouth (12). Strains were 
struck out from -80oC stocks onto LB agar plates and incubated overnight at 37oC. For 
each strain, 3 mL LB broth aliquots were inoculated from the plates and incubated 
overnight at 37oC. At stationary phase, the overnights were diluted one to one hundred in 
LB. Added 150 µL of diluted bacteria to five technical replicate wells each on a Costar 
Serocluster 96 well “U” bottom, vinyl plate (REF 2797). Place plate in a small container 
with a moistened paper towel to act as a humidity chamber. Incubate at 37oC overnight. 
Invert plate over waste container and shake gently. Rinse twice by gently submerging in 
distilled water. Tamp dry on paper towels. Add 180 µL of 0.1% crystal violet to each 
well and let sit for ten minutes. Invert plate over waste tray and shake gently. Rinse plate 
twice gently in distilled water, invert and tamp down on paper towels to dry. add 150 µL 
80% ethanol to each well, wait five minutes for the crystal violet to solubilize, and read 
plate at OD550 on a Biotek Synergy 2. 
 
RNAseq analysis. In previous work (1), B. thailandensis strains were examined to 
elucidate the putative regulons for GbdR1 and GbdR2. WT. ΔgbdR1, ΔgbdR2, and 
ΔgbdR1ΔgbdR2 strains were grown in MOPS media with 20 mM pyruvate in the 
presence or absence of 1 mM choline. Inductions were done in duplicate and RNAseq 
was performed as previously described. Comparisons were filtered as follows: 1) WT + 
choline versus WT no choline log fold change (expressed as log2(X)) ≥ -2 or ≤ 2, WT + 
choline versus ΔgbdR2 + choline ≤-2 or ≥2 and significance ≤ 0.05, 3) WT + choline 
versus ΔgbdR1ΔgbdR2 + choline ≤-2 or ≥2 and significance ≤ 0.05. Applying these 
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filters results in a comparison of genes that are up or down regulated in ΔgbdR2 and 
ΔgbdR1ΔgbdR2 compared to the WT, but not due to the presence or absence of choline. 
Presumably, the results include genes that might be responsible for the colony 
morphology and biofilm phenotypes. Data is available at NCBI’s Gene Expression 
Omnibus, accession GSE81652. 
 
A.3 Results and Discussion. 
 
  Our previous work investigating the regulons of GbdR1, GbdR2, and SouR, as 
well as their role in glycine betaine catabolism, hinted at some relationship between 
strains containing a deletion of gbdR2 and the uncharacterized GATR, I1350 (1). 
However the nature of this putative relationship remained unclear and did not seem to 
directly relate the presence or absence of choline. In other instances, GATRs have been 
shown to impinge on the regulation of promoters primarily ascribed to another GATR, as 
in the case of GbdR and SouR in P. aeruginosa (13), as well as for GbdR and CdhR 
(unpublished, Jamie Meadows). Thus, it was tempting to speculate that there might be 
some regulatory cross-talk between GbdR2 and I1350 in B. thailandensis. I1350 is a 
particularly interesting GATR because of synteny with a major capsule operon in B. 
thailandensis, possibly being transcribed as part of the same operon. The proximity of 
this GATR to CPS-IV (I1351 to I1362), as well as previous RNAseq data which showed 
changes in expression being relatively uniform across I1350 to I1362, make it attractive 
to consider that I1350 might be involved in the regulation of this capsule. This particular 
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capsule operon is homologous to capsule IV in B. pseudomallei. Although capsule I of B. 
pseudomallei is primarily responsible for virulence, experiments in the Golden Syrian 
Hamster model suggested that CPS-IV may have some contribution to virulence. 
However, the role of CPS-IV with respect to the biology of B. pseudomallei or B. 
thailandensis is not well understood or particularly well studied due to being 
overshadowed by the clear importance of CPS-I.  
  In the course of working with B. thailandensis strains, it was noticed that some of 
the deletion mutants exhibited differential colony morphologies. This difference was 
particularly notable when a number of cells were spotted onto plates as opposed to 
colonies arising from single colony forming units. Spotting bacteria onto R2B plates 
consistently yielded a striking ‘stained glass’ morphology for ΔgbdR2 and 
ΔgbdR1ΔgbdR2 strains, but not for WT or ΔgbdR1 strains (Figure 5.1 A). This 
morphological phenotype was also present in the ΔI1350. Unfortunately, none of the 
various GATR complementation strains we constructed altered this morphological 
phenotype (data not shown). This was true despite the GbdR1 and GbdR2 
complementation strains having been shown to phenotypically complement defect in 
growth of gbdR1 and gbdR2 deletion strains when grown on choline or its derivative 
metabolites as sole carbon sources (1). The inability of clearly functional catabolic 
complementation to alter this morphological phenotype suggests that the hypothetical 
relationship between gbdR2 is incorrect, but the possibility existed that other explanations 
could account for the disparity.  
  Because of the potential of capsule modification to impinge upon biofilm 
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formation due to alterations of the cell’s exterior surface, we opted to utilize the 
microtiter plate biofilm assay popularized by the O’Toole lab (12). Coincident with this 
project, many other GATR deletion strains had been produced (Table 5.1). We included 
the GATR deletion strains available to us because of the simplicity of the screen and 
achieved surprising results (Figure 5.1 B). Seven out of the eleven deletion strains 
appeared to have some level of defect in biofilm formation. Barring a massive level of 
cross-talk between these regulators, it became evident that the source of the biofilm 
defect was more likely due to other mutations, perhaps selected for by the process 
involved for subculturing and creating these strains.  
  Another possible explanation for the apparent biofilm defect in our various 
deletion strains was that the phenotype is due to a subpopulation within the wild type 
stock that contains the responsible mutation or that the unknown factor regulated by 
phase variation. In order to untangle these possible explanations, the wild type stock was 
struck on LB agar plates and isolated colonies were selected and subjected to our biofilm 
assay (Figure 5.2 A). This resulted in many clones exhibiting typical levels of biofilm 
formation, and several that exhibited a defect. Clones 9 and 10 were further subcultured 
and struck for isolation on LB agar plates. These subclones were again subjected to the 
biofilm assay and were found to yield phenotypes consistent with their parental clone 
(Figure 5.2 B). Additional experimentation was consistent with these results (data not 
shown). The absence of any biofilm phenotype revertants in either direction makes it 
unlikely that phase variation is the cause of the phenotypes. Rather, the most likely 
explanation is that our original stock of wild type B. thailandensis E264 contains a 
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subpopulation that exhibits a biofilm formation defect. This is critical to note as we 
intend to further investigate many of the GATR deletion strains we created for as of yet 
unknown phenotypes and were this not known, it could convolute our future results.  
  In order to derive some explanation for our observed phenotypes, we delved back 
into our old RNAseq data (Table 5.2). Because of the strains and conditions used, it was 
possible to eliminate genes expression changes that were specifically due to choline, 
which the gbdR1 and gbdR2 deletions impinge directly on. Also because both ΔgbdR2 
and ΔgbdR1ΔgbdR2 expressed the colony morphology and biofilm deficient phenotypes, 
we could eliminate disparities between the two strains unrelated to these particular 
phenotypes and compare both to wild type. Doing so reveals two large operons that may 
be responsible for these phenotypes. The first, I1350-I1357, contains the capsule operon 
linked with the putative GATR regulating it, I1350, which initially captured our interest. 
The second putative operon, I2674-I268, contains a putative two-component regulatory 
response system and genes that are bioinformatically predicted to be involved with the 
assembly of fimbriae. The altered expression of capsule and fimbriae genes is a logical 
source for the observed phenotypes, as they could both easily be imagined to affect cell to 
cell or cell to surface interactions. Both of these clusters are present in B. pseudomallei, 
although neither has been directly tied to virulence. There are other fimbriae genes that 
have been associated with both virulence in B. pseudomallei and biofilm formation in B. 
cenocepacia (14, 15). Our experiments with these strains utilizing the Madagascar 
hissing cockroach infection model did not suggest any impact on virulence (data not 
shown) (16). However, the question of why these genes are expressed differentially 
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remains. Further investigation would require the construction of deletion and 
complementation strains to explain the phenotype at a minimum. At present, we are 
content with this explanation and subsequent genetic manipulation for use in our research 
in B. thailandensis E264 has been with a WT subclone confirmed for biofilm production.  
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A.4 Appendix A Figures 
 
Figure A.1 – Searching for a link between phenotype and genotype.  
(A) Deletion strains of B. thailandensis E264 on R2B plates exhibited consistent 
morphological phenotypes. WT and ΔgbdR1 have topologically flatter, filled in centers. 
ΔgbdR2, ΔgbdR1ΔgbdR2, and ΔI1350 exhibited an unusual ‘stained glass’ morphology. 
(B) Available GATR deletion strains were tested for biofilm formation utilizing crystal 
violet staining. Surprisingly, seven out of the twelve strains tested exhibited a defect in 
biofilm formation.  
 
Figure A.2 – Biofilm phenotype subculturing in B. thailandensis E264.  
(A) Subclones of WT B. thailandensis E264 from our stock vile were isolated and 
subjected to crystal violet biofilm assay. Both biofilm positive and biofilm negative 
subclones were present. (B) Selected subclones nine and ten were struck out for isolation 
and secondarily subclones. These subclones were also subjected to crystal violet biofilm 
assaying, and their phenotypes were consistent with the subpopulation from which each 
was derived.  
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A.5 Appendix A Tables 
 
Table A.1 – Strain Utilized in Study. 
A list of strains derived from Burkholderia thailandensis E264 utilized in the experiments 
described in this chapter. AN3, AN16, AN19, and AN126 were first described in 
previously published work (1).  
 
Table A.2 – RNAseq Analysis Correlation.  
Previously obtained RNAseq results were differentially filtered in order to seek a 
potential explanation for the phenotypes seen in ΔgbdR2 (AN19) and ΔgbdR1ΔgbdR2 
(AN16) strains, but do not include changes in gene expression that are due to the 
presence of choline. Two sets of interesting genes were downregulated in relation to the 
WT strain (MJ358). These included an operon involving capsule production and its 
presumptive GATR regulator, as well as an operon bioinformatically predicted to be 
involved in the assembly and transport of fimbriae. ‘m’ in between strain names signifies 
subtractive comparison. ‘.lfc’ signifies log fold change expressed as either positive or 
negative log2(x). ‘.p’ signifies the calculated significance of the correlation. 
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                     Appendix B – A prophage affecting B. thailandensis E264.  
 
B.1 Introduction. 
  B. thailandensis strains, including E264, are known to harbor various phages that 
are capable of infecting B. mallei, B. pseudomallei, and other bacteria (1). The degree to 
which these phages have been categorized often is dependent on their immediate 
experimental utility. The status of B. mallei and B. pseudomallei as select agents has 
stimulated interest in the identification of phages which might potentially infect them, 
either as diagnostic tools or potentially as therapeutics due to their capacity for drug 
resistance (2). Additionally, the identification of phages capable of infecting B. 
pseudomallei in soil samples could be used as an indicator of the likely presence of B. 
pseudomallei, which is not always consistently isolated from soil where it is known to be 
present (3). 
  While generating B. thailandensis E264 ΔgbdR1ΔgbdR2ΔsouR during the course 
of exploration of glycine betaine catabolism, we noticed the emergence of a lytic phage 
in one of the two clones, AN206 (Figure B.1 A). Bacteria from the plate were re-struck 
unto two new LB plates, with one being struck using inoculum including presumptive 
plaques and the other struck using inoculum seemingly clear of any plaques. The plate 
struck using inoculum was clearly riddled with phage (left) while the other plate 
contained no evidence of plaques (right) (Figure B.1 B). The initial preparation of phage 
was collected from this left plate by adding 10 mL of 10 mM Tris pH = 7.4 to the plate to 
rinse its surface, then filter sterilizing the collected liquid with a 0.22 µ filter. Adding 5 
µL drops to an LB plate inoculated with a fresh lawn of wild type B. thailandensis E264 
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resulted in a large, totally cleared zone after an overnight incubation at 37oC (Figure B.1 
C). These findings suggested the presence of a phage, which we have designated as 
“There are some who call me Tim” or φTim for short (4). Because of the interest in 
phages affecting Burkholderiales, we endeavored to identify the phage.  
 
B.2 Methods. 
Amplification of bacteriophage. B. thailandensis E264 was grown overnight at 37oC in 3 
mL LB media. It was then diluted by adding 1 mL of overnight to 50 mL LB, add 10 µL 
of phage, and incubated overnight at 37oC. Cells and debris were pelleted by spinning at 
2500 rpm for 15 minutes in a 4.2 rotor. The supernatant was filter sterilized using a .22 
µm filter.  
 
Rough bacteriophage DNA isolation. To 5 mL of filtered bacteriophage, add 10 µL 
DNase I (NEB) and incubate on ice for 1 hour to eliminate the majority of carry-over 
bacterial DNA. The filtrate was aliquoted to ten 1.5 mL microcentrifuge tubes, 300 µL 
each. To each tube, 0.5 µL glycogen, 33 µL 3 M NaOAc pH = 5.2, and 300 µL phenol 
chloroform isoamyl alcohol (50:49:1) were added. The tubes were vortexed thoroughly, 
then centrifuged for four minutes at 14,000 rpm in a table top microcentrifuge at room 
temperature. The aqueous phase was saved to a clean 1.5 mL microcentrifuge tube, to 
which 900 µL ethanol was added. Tubes were mixed by inversion and stored at -80oC 
overnight. Thawed samples were then spun at 14,000 rpm for 30 minutes at 4oC. The 
pellets were washed with 800 µL 80% ethanol, then air dried for five minutes. Each pellet 
was resuspended in 25 µL of water and pooled.  
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Cloning of phage DNA into pGEM-T-Easy vector. 10 µL of phage DNA was combined 
with 5 µL cutsmart buffer (New England Biolabs (NEB)), 33 µL water, and 2 µL AluI 
(NEB #R0137S) for 40 minutes at 37oC. The digestion was stopped by incubating at 
80oC for 5 minutes. 0.5 µL Taq polymerase and 1 uL 10 mM dATP were added and the 
reaction, and it was incubated for 20 minutes at 72oC. The reaction was cleaned up using 
a GeneJET Gel Extraction and DNA cleanup Micro Kit following the standard protocol 
for reaction cleanup (Thermo Scientific #K0832). The AluI cut, adenylated phage DNA 
was then ligated into pGEM-T-Easy (Promega #A1360) following the manufacturers 
protocol. The ligation reaction was used to transform chemically competent Escherichia 
coli DH5α cells and selected on LB plates with 100 µg/mL carbenicillin. Plasmid DNA 
from clones was isolated using a GeneJET Plasmid Miniprep Kit (Thermo Scientific 
#K0503). Plasmid DNA was screened for inserts by digesting with EcoRI-HF (NEB 
#R3101), and five clones positive for inserts were sent for sequencing using the M13F 
primer.  
 
B.3 Results and Discussion. 
  Sequencing inserts derived from a crude preparation of phage DNA resulted in 
nBLAST hits exactly matching sections of II1331, II1332, and II1364 found in B. 
thailandensis E264 (Table B.1), indicating that we have isolated the lytic form of a 
prophage. These genes are part of a previously recognized prophage-like genomic island 
that was not observed to be active in E264, but would be categorized as a member of the 
Myoviridae (5). The Myoviridae are a group of non-enveloped bacteriophages with 
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contractile tails, the most common example being the famous bacteriophage T4 (6). This 
particular genomic island was present in roughly 25% of a survey of 29 strains of 
environmentally isolated B. thailandensis (7). BLAST results for the inserts homologous 
to II1331 and II1332 suggested close similarity to phages in B. pseudomallei ((φE122, 
accession CP000624), (φX216, accession JX681814), (Burkholderia phage BEK, 
accession CP008753), (φ52237, accession DQ087285)) and in B. thailandensis E202 
(φE202, accession CP000623), and B. cenocepacia C6433 (Burkholderia phage KS14, 
accession HM461982 (8)).. The size of this phage genome is predicted to be between 35 
and 38 kilobases depending on the bioinformatics parameters, and in our hands the 
prepared genomic DNA appeared as a single prominent band in this approximate size 
range (data not shown).  
  Interestingly, these similar phages do not contain sequences homologous to our 
II1364 insert, although this gene falls within the confines of the bioinformatically 
predicted prophage-like island (5). II1364 is predicted to code for a DNA 
methyltransferase, which are often used to protect phage DNA from cleavage by host 
endonucleases (9). Although it is possible this phage may have been previously 
incidentally isolated and tested for its ability to infect B. pseudomallei or B. mallei 
without being further analyzed and annotated, it does not appear that this phage has been 
previously sequenced and submitted to NCBI apart from being a part of the B. 
thailandensis E264 genome. Further characterization of this phage may reveal it to be 
another useful tool in the study of Burkholderiales.  
 
B.4 Appendix B Figure 
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Figure B.1 – A bacteriophage infecting B. thailandensis E264. (A) Plaques were initially 
observed when plating a particular clone of a deletion strain, the plate on the left side of 
the panel. (B) The plate with apparent plaques was re-struck onto two new LB plates, one 
with inoculum including the plaque (left) and one with inoculum seemingly free of 
plaques (right). (C) An LB plate was struck for confluency with B. thailandensis E264, 
and a 5 µL drop of filter sterilized phage preparation was added with a 5 µL drop of 
filtered 10 mM Tris pH = 7.4 as a negative control. The plate was then incubated 
overnight at 37oC.  
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B.5 Appendix B Table 
Table B.1 – Sequencing results for cloned inserts. Sequencing results were subjected to 
nBLAST and bioinformatic predictions were added to the table. Highlighted entries 
indicate genes that may be phage-associated.  
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